Represent

Lobbying
Lobbying by AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Lobbying Relationship

Client

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

More records

Lobbying firm

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

More records

1/2/24 AAO-HNS letter to CMS on the agency's proposed rule on federal independent dispute resolution operations of the No Surprises Act. 1/8/24 Coalition letter to Administrator of the Centers for Medicare and Medicaid Services (CMS); includes issues relating to classification/coverage of prescription drugs and exchange network adequacy standards. 1/9/24 AAO-HNS led letter to House Energy & Commerce and Ways & Means Committees opposing the Medicare Audiology Access Improvement Act (H.R. 6445) 1/24/24 Coalition letter to leadership of the Senate HELP Committee opposing Section 5 of the "Health Care PRICE Transparency Act 2.0." Suggests pursuing alternative course of action to better support ASCs. 2/15/24 Coalition letter thanking members for reauthorizing the "Dr. Lorna Breen Health Care Provider Protection Act." Encourages members to continue supporting mental health services for healthcare professionals. 2/16/24 Letter to FDA; issues relating to public comment and FDA best practices. 3/1/24 Coalition letter to Director of the Center for Medicare at the Centers for Medicare and Medicaid Services (CMS); includes issues relating to network adequacy, the Star Ratings system, and prior authorization. 3/15/24 Letter to Chair and Ranking Member of House Committee on Education and the Workforce; Issues relating to prior authorization reform and administrative burden; including ERISA and H.R. 2630 (The Safe Step Act). 3/18/24 Letter to Reps. Michael Burgess and Diana DeGette offering the AAO-HNS' support of H.R. 766 (Dr. Michael C. Burgess Preventive Health Savings Act) and reform of the CBO scoring system. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to prior authorization, in general Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general.
1/2/24 AAO-HNS letter to CMS on the agency's proposed rule on federal independent dispute resolution operations of the No Surprises Act. 1/8/24 Coalition letter to Administrator of the Centers for Medicare and Medicaid Services (CMS); includes issues relating to classification/coverage of prescription drugs and exchange network adequacy standards. 1/17/24 Coalition letter urging House and Senate leadership to reverse the 3.37% cut to Medicare physician payments that took effect on January 1st, 2024. 3/1/24 Coalition letter to Director of Medicare at the Centers for Medicare and Medicaid Services (CMS); includes issues relating to network adequacy, the Star Ratings system, and prior authorization. Issues pertaining to prior authorization, in general Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general. Issues related to hearing healthcare, in general. Issues pertaining to step therapy, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general
1/9/24 Coalition to letter to Chairs and Ranking Members of the House and Senate Committees on Appropriations urging that appropriations for FY 2024 retain the FDA's authority to regulate tobacco products and do not cut funding from the CDC's Office on Smoking and Health (OSH). 3/25/24 Coalition letter to the Chair and Ranking Member of the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. 3/25/24 Coalition letter to the Chair and Ranking Member of the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.
1/9/24 Coalition to letter to Chairs and Ranking Members of the House and Senate Committees on Appropriations urging that appropriations for FY 2024 retain the FDA's authority to regulate tobacco products and do not cut funding from the CDC's Office on Smoking and Health (OSH). 1/17/24 Coalition letter urging House and Senate leadership to reverse the 3.37% cut to Medicare physician payments that took effect on January 1st, 2024. 3/18/24 Letter to Reps. Michael Burgess and Diana DeGette offering the AAO-HNS' support of H.R. 766 (Dr. C Burgess Preventive Health Savings Act) and reform of the CBO scoring system. 3/25/24 Coalition letter to the Chair and Ranking Member of the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. 3/25/24 Coalition letter to the Chair and Ranking Member of the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. Issues pertaining to the budget and appropriations, in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Duration: November 1, 2007 to present

General Issues: Health Issues, Medicare/Medicaid, Tobacco, Budget/Appropriations, Veterans, Torts, Taxation/Internal Revenue Code, Small Business, Copyright/Patent/Trademark, Pharmacy, Trade (Domestic & Foreign), Consumer Issues/Safety/Protection, Banking

Spending: about $11,366,217 (But it's complicated. Here's why.)

Agencies lobbied since 2007: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Veterans Affairs - Dept of (VA), Health Resources & Services Administration (HRSA), Federal Trade Commission (FTC), Labor - Dept of (DOL), Treasury - Dept of, White House Office, U.S. Trade Representative (USTR), Centers For Disease Control & Prevention (CDC), Housing & Urban Development - Dept of (HUD), Agency for Healthcare Research & Quality (AHRQ), Natl Institutes of Health (NIH), Government Accountability Office (GAO), Office of Management & Budget (OMB), Internal Revenue Service (IRS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), General Services Administration (GSA), Consumer Product Safety Commission (CPSC), Social Security Administration (SSA), Social Security Administration (SSA),, Occupational Safety & Health Administration (OSHA), Occupational Safety & Health Administration (OSHA),, Centers For Medicare and Medicaid Services (CMS),, Office of Personnel Management (OPM), Department of Health and Human Services Food and Drug Administration

Bills mentioned

H.R.564: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Posey (R-Fla.)

H.R.1539: Early Hearing Detection and Intervention Act of 2017

Sponsor: Brett Guthrie (R-Ky.)

S.652: Early Hearing Detection and Intervention Act of 2017

Sponsor: Rob Portman (R-Ohio)

H.R.3354: Interior and Environment, Agriculture and Rural Development, Commerce,...

Sponsor: Ken Calvert (R-Calif.)

H.R.1652: Over-the-Counter Hearing Aid Act of 2017

Sponsor: Joseph P. Kennedy III (D-Mass.)

S.670: Over-the-Counter Hearing Aid Act of 2017

Sponsor: Elizabeth Warren (D-Mass.)

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

H.R.1628: American Health Care Act of 2017

Sponsor: Diane Black (R-Tenn.)

H.R.1156: Patient Access to Higher Quality Health Care Act of 2017

Sponsor: Sam Johnson (R-Texas)

H.R.849: Protecting Seniors Access to Medicare Act

Sponsor: Phil Roe (R-Tenn.)

S.260: Protecting Seniors' Access to Medicare Act of 2017

Sponsor: John Cornyn (R-Texas)

S.251: Protecting Medicare from Executive Action Act of 2017

Sponsor: Ron Wyden (D-Ore.)

H.R.2276: Audiology Patient Choice Act of 2017

Sponsor: Tom Rice (R-S.C.)

H.R.1136: FDA Deeming Authority Clarification Act of 2017

Sponsor: Tom Cole (R-Okla.)

H.R.1215: Protecting Access to Care Act of 2017

Sponsor: Steve King (R-Iowa)

H.R.1704: ACCESS Act of 2017

Sponsor: Richard Hudson (R-N.C.)

H.R.1344: Early Hearing Detection and Intervention Act of 2015

Sponsor: Brett Guthrie (R-Ky.)

S.2424: Early Hearing Detection and Intervention Act of 2015

Sponsor: Rob Portman (R-Ohio)

H.R.1741: Truth in Healthcare Marketing Act of 2015

Sponsor: Larry Bucshon (R-Ind.)

H.R.1859: Ensuring Children's Access to Specialty Care Act of 2015

Sponsor: Chris Collins (R-N.Y.)

S.2782: Ensuring Children's Access to Specialty Care Act of 2016

Sponsor: Roy Blunt (R-Mo.)

S.2978: Protect Continuing Physician Education and Patient Care Act

Sponsor: John Barrasso (R-Wyo.)

S.2511: Improving Health Information Technology Act

Sponsor: Lamar Alexander (R-Tenn.)

H.R.1116: Medicare Audiology Services Enhancement Act of 2015

Sponsor: Gus Bilirakis (R-Fla.)

H.R.2519: Audiology Patient Choice Act of 2015

Sponsor: Lynn Jenkins (R-Kan.)

H.R.3242: Child Nicotine Poisoning Prevention Act of 2015

Sponsor: Susan Brooks (R-Ind.)

S.142: Child Nicotine Poisoning Prevention Act of 2015

Sponsor: Bill Nelson (D-Fla.)

S.2175: Department of Veterans Affairs Provider Equity Act

Sponsor: Jon Tester (D-Mont.)

H.R.353: Veterans' Access to Hearing Health Act of 2015

Sponsor: Sean Duffy (R-Wis.)

S.564: Veterans Hearing Aid Access and Assistance Act

Sponsor: Jerry Moran (R-Kan.)

H.R.3471: Veterans Mobility Safety Act of 2016

Sponsor: Jackie Walorski (R-Ind.)

H.R.2: Medicare Access and CHIP Reauthorization Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

H.R.1470: SGR Repeal and Medicare Provider Payment Modernization Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

H.R.1190: Protecting Seniors' Access to Medicare Act of 2015

Sponsor: Phil Roe (R-Tenn.)

S.141: Protecting Seniors' Access to Medicare Act of 2015

Sponsor: John Cornyn (R-Texas)

H.R.3309: Flex-IT 2 Act

Sponsor: Renee Ellmers (R-N.C.)

H.R.1919: Steve Gleason Act of 2015

Sponsor: Cathy McMorris Rodgers (R-Wash.)

S.2425: Patient Access and Medicare Protection Act

Sponsor: Rob Portman (R-Ohio)

H.R.2568: Fair Medical Audits Act of 2015

Sponsor: George Holding (R-N.C.)

H.R.2513: PACE Act of 2015

Sponsor: Sam Johnson (R-Texas)

H.R.3940: Meaningful Use Hardship Relief Act of 2015

Sponsor: Tom Price (R-Ga.)

H.R.4750: Adoption Leave for Military Families Act

Sponsor: Tom MacArthur (R-N.J.)

H.R.662: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Posey (R-Fla.)

S.441: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Nelson (D-Fla.)

H.R.1375: Child Nicotine Poisoning Prevention Act of 2015

Sponsor: Elizabeth Esty (D-Conn.)

H.R.2058: FDA Deeming Authority Clarification Act of 2015

Sponsor: Tom Cole (R-Okla.)

H.R.293: To amend title XI of the Social Security Act to exempt from manufacturer...

Sponsor: Michael C. Burgess (R-Texas)

H.R.4015: SGR Repeal and Medicare Provider Payment Modernization Act of 2014

Sponsor: Michael C. Burgess (R-Texas)

S.2000: SGR Repeal and Medicare Provider Payment Modernization Act of 2014

Sponsor: Max Baucus (D-Mont.)

S.2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014

Sponsor: Ron Wyden (D-Ore.)

S.2122: Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act...

Sponsor: Orrin G. Hatch (R-Utah)

S.2157: Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act...

Sponsor: Ron Wyden (D-Ore.)

H.R.4302: Protecting Access to Medicare Act of 2014

Sponsor: Joe Pitts (R-Pa.)

H.R.2330: Medicare Audiology Services Enhancement Act of 2013

Sponsor: Gus Bilirakis (R-Fla.)

H.R.4035: Access to Hearing Healthcare Act of 2014

Sponsor: Jim McDermott (D-Wash.)

S.2046: Access to Hearing Healthcare Act of 2014

Sponsor: Sherrod Brown (D-Ohio)

H.R.4695: To amend title XVIII of the Social Security Act to add sleep apnea...

Sponsor: Michael C. Burgess (R-Texas)

H.R.4187: DISARM Act of 2014

Sponsor: Peter Roskam (R-Ill.)

H.R.5304: Audiology Patient Choice Act of 2014

Sponsor: Lynn Jenkins (R-Kan.)

H.R.5539: To amend title XI of the Social Security Act to exempt from manufacturer...

Sponsor: Michael C. Burgess (R-Texas)

H.R.4750: Standard of Care Protection Act of 2014

Sponsor: Phil Gingrey (R-Ga.)

H.R.5486: Child Nicotine Poisoning Prevention Act of 2014

Sponsor: Elizabeth Esty (D-Conn.)

S.2581: Child Nicotine Poisoning Prevention Act of 2014

Sponsor: Bill Nelson (D-Fla.)

H.R.1427: Truth in Healthcare Marketing Act of 2013

Sponsor: Larry Bucshon (R-Ind.)

H.R.3742: Antibiotic Development to Advance Patient Treatment Act of 2013

Sponsor: Phil Gingrey (R-Ga.)

H.R.523: Protect Medical Innovation Act of 2013

Sponsor: Erik Paulsen (R-Minn.)

S.232: Medical Device Access and Innovation Protection Act

Sponsor: Orrin G. Hatch (R-Utah)

H.R.3508: To amend title 38, United States Code, to clarify the qualifications of...

Sponsor: Sean Duffy (R-Wis.)

S.2311: A bill to amend title 38, United States Code, to include licensed...

Sponsor: Jon Tester (D-Mont.)

H.R.351: Protecting Seniors' Access to Medicare Act of 2013

Sponsor: Phil Roe (R-Tenn.)

S.351: Protecting Seniors' Access to Medicare Act of 2013

Sponsor: John Cornyn (R-Texas)

H.R.1331: Electronic Health Records Improvement Act

Sponsor: Diane Black (R-Tenn.)

H.R.2914: Promoting Integrity in Medicare Act of 2013

Sponsor: Jackie Speier (D-Calif.)

H.R.2810: SGR Repeal and Medicare Beneficiary Access Act of 2013

Sponsor: Michael C. Burgess (R-Texas)

H.R.1827: Pediatric Subspecialty and Mental Health Workforce Reauthorization Act...

Sponsor: Joe Courtney (D-Conn.)

H.R.1473: Standard of Care Protection Act of 2013

Sponsor: Phil Gingrey (R-Ga.)

H.R.792: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Posey (R-Fla.)

H.R.2817: Protect Patient Access to Quality Health Professionals Act of 2013

Sponsor: Andy Harris (R-Md.)

H.R.2094: School Access to Emergency Epinephrine Act

Sponsor: Phil Roe (R-Tenn.)

H.R.8:

Sponsor: John A. Boehner (R-Ohio)

H.R.451: Healthcare Truth and Transparency Act of 2011

Sponsor: John Sullivan (R-Okla.)

H.R.1955: Children's Access to Reconstructive Evaluation & Surgery (CARES) Act of...

Sponsor: Pat Tiberi (R-Ohio)

S.1045: Children's Access to Reconstructive Evaluation & Surgery (CARES) Act of...

Sponsor: Mary L. Landrieu (D-La.)

H.R.3630: Middle Class Tax Relief and Job Creation Act of 2012

Sponsor: Dave Camp (R-Mich.)

H.R.452: Medicare Decisions Accountability Act of 2011

Sponsor: Phil Roe (R-Tenn.)

S.668: Health Care Bureaucrats Elimination Act

Sponsor: John Cornyn (R-Texas)

H.R.2140: Medicare Hearing Health Care Enhancement Act of 2011

Sponsor: Mike Ross (D-Ark.)

S.3242: Medicare Hearing Health Care Enhancement Act of 2012

Sponsor: Robert Menendez (D-N.J.)

H.R.5: Protecting Access to Healthcare Act

Sponsor: Phil Gingrey (R-Ga.)

H.R.6598: Electronic Health Records Improvement Act

Sponsor: Diane Black (R-Tenn.)

H.R.8: American Taxpayer Relief Act of 2012

Sponsor: Dave Camp (R-Mich.)

S.218: Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of...

Sponsor: John Ensign (R-Nev.)

S.1099: Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of...

Sponsor: Roy Blunt (R-Mo.)

S.1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Nelson (D-Fla.)

H.R.2: Repealing the Job-Killing Health Care Law Act

Sponsor: Eric Cantor (R-Va.)

H.R.969: Medical Practice Freedom Act of 2011

Sponsor: Tom Price (R-Ga.)

H.R.2092: To amend the Internal Revenue Code of 1986 to repeal the excise tax on...

Sponsor: Mike Grimm (R-N.Y.)

S.1278: A bill to amend the Internal Revenue Code of 1986 to repeal the excise...

Sponsor: Olympia J. Snowe (R-Maine)

H.R.1256: Medicare Physician Payment Transparency and Assessment Act of 2011

Sponsor: Jim McDermott (D-Wash.)

S.756: Medicare Data Access for Transparency and Accountability Act

Sponsor: Charles E. Grassley (R-Iowa)

S.848: Consumer Information Enhancement Act of 2011

Sponsor: John Cornyn (R-Texas)

H.R.1700: Medicare Patient Empowerment Act

Sponsor: Tom Price (R-Ga.)

S.1042: Medicare Patient Empowerment Act

Sponsor: Lisa Murkowski (R-Alaska)

H.R.1476: Integrity in Medicare Advanced Diagnostic Imaging Act of 2011

Sponsor: Jackie Speier (D-Calif.)

H.R.531: Access to Frontline Health Care Act of 2011

Sponsor: Bruce Braley (D-Iowa)

H.R.1217: To repeal the Prevention and Public Health Fund.

Sponsor: Joe Pitts (R-Pa.)

H.R.2112: Consolidated and Further Continuing Appropriations Act, 2012

Sponsor: Jack Kingston (R-Ga.)

S.365: Budget Control Act of 2011

Sponsor: Tom Harkin (D-Iowa)

H.R.1852: Children's Hospital GME Support Reauthorization Act of 2011

Sponsor: Joe Pitts (R-Pa.)

S.958: Children's Hospital GME Support Reauthorization Act of 2011

Sponsor: Bob Casey (D-Pa.)

H.R.816: Provider Shield Act of 2011

Sponsor: Phil Gingrey (R-Ga.)

H.R.157: Health Care Safety Net Enhancement Act of 2011

Sponsor: Pete Sessions (R-Texas)

H.R.4: Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy...

Sponsor: Dan Lungren (R-Calif.)

H.R.1639: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Bill Posey (R-Fla.)

S.1165: Button Cell Battery Safety Act of 2011

Sponsor: John D. Rockefeller IV (D-W.Va.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

H.R.1246: Early Hearing Detection and Intervention Act of 2009

Sponsor: Lois Capps (D-Calif.)

S.3199: Early Hearing Detection and Intervention Act of 2010

Sponsor: Olympia J. Snowe (R-Maine)

H.R.5295: Healthcare Truth and Transparency Act of 2010

Sponsor: John Sullivan (R-Okla.)

H.R.1339: Children's Access to Reconstructive Evaluation & Surgery (CARES) Act of...

Sponsor: Carolyn McCarthy (D-N.Y.)

H.R.4691: Temporary Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4851: Continuing Extension Act of 2010

Sponsor: Sander M. Levin (D-Mich.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.3024: Medicare Hearing Health Care Enhancement Act of 2009

Sponsor: Mike Ross (D-Ark.)

H.R.4895: Honesty in Postal Manager Contracts Act

Sponsor: Gerald E. Connolly (D-Va.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.4994: Medicare and Medicaid Extenders Act of 2010

Sponsor: John Lewis (D-Ga.)

H.R.5712: Physician Payment and Therapy Relief Act of 2010

Sponsor: Sander M. Levin (D-Mich.)

H.R.1676: Prevent All Cigarette Trafficking Act of 2009

Sponsor: Anthony Weiner (D-N.Y.)

S.1147: Prevent All Cigarette Trafficking Act of 2009

Sponsor: Herb Kohl (D-Wis.)

H.R.5178: Smuggled Tobacco Prevention Act of 2010

Sponsor: Lloyd Doggett (D-Texas)

H.R.5297: Small Business Jobs Act of 2010

Sponsor: Barney Frank (D-Mass.)

H.R.2345: To amend the Fair Credit Reporting Act to provide for an exclusion from...

Sponsor: John Adler (D-N.J.)

S.3416: A bill to amend the Fair Credit Reporting Act to provide for an...

Sponsor: John Thune (R-S.D.)

S.3987: Red Flag Program Clarification Act of 2010

Sponsor: John Thune (R-S.D.)

H.R.4985: Medicare Decisions Accountability Act of 2010

Sponsor: Phil Roe (R-Tenn.)

H.R.1: American Recovery and Reinvestment Act of 2009

Sponsor: David R. Obey (D-Wis.)

H.R.1256: Family Smoking Prevention and Tobacco Control Act

Sponsor: Henry A. Waxman (D-Calif.)

S.982: Family Smoking Prevention and Tobacco Control Act

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.2891: Access to Frontline Health Care Act of 2009

Sponsor: Bruce Braley (D-Iowa)

H.R.3584: Health Care Consumer Protection Act of 2009

Sponsor: J. Randy Forbes (R-Va.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.2718: Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009

Sponsor: Jim Cooper (D-Tenn.)

S.1110: Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009

Sponsor: John D. Rockefeller IV (D-W.Va.)

S.950: Medicare Patient Access to Physical Therapists Act of 2009

Sponsor: Blanche Lincoln (D-Ark.)

S.1776: Medicare Physician Fairness Act of 2009

Sponsor: Debbie Stabenow (D-Mich.)

H.R.3961: An Act to extend expiring provisions of the USA PATRIOT Improvement and...

Sponsor: John D. Dingell (D-Mich.)

H.R.4371: To amend title XVIII of the Social Security Act to continue using 2009...

Sponsor: Charlie Gonzalez (D-Texas)

H.CON.RES.85: Setting forth the congressional budget for the United States Government...

Sponsor: John M. Spratt Jr. (D-S.C.)

S.CON.RES.13: An original concurrent resolution setting forth the congressional budget...

Sponsor: Kent Conrad (D-N.D.)

H.R.3326: Department of Defense Appropriations Act, 2010

Sponsor: John P. Murtha (D-Pa.)

H.RES.976: Providing for consideration of the Senate amendment to the bill (H.R....

Sponsor: Chellie Pingree (D-Maine)

H.R.1188: Access to Emergency Medical Services Act of 2009

Sponsor: Bart Gordon (D-Tenn.)

H.R.1998: Health Care Safety Net Enhancement Act of 2009

Sponsor: Bart Gordon (D-Tenn.)

H.R.2844: Medicare Payment Improvement Act of 2009

Sponsor: Ron Kind (D-Wis.)

H.R.2260: Healthcare Truth and Transparency Act of 2007

Sponsor: John Sullivan (R-Okla.)

H.R.3173: Improving Emergency Medical Care and Response Act of 2007

Sponsor: Henry A. Waxman (D-Calif.)

S.1873: Improving Emergency Medical Care and Response Act of 2007

Sponsor: Barack Obama (D-Ill.)

H.CON.RES.195: Expressing the sense of the Congress that a National Dysphagia Awareness...

Sponsor: Zach Wamp (R-Tenn.)

H.R.1665: Medicare Hearing Health Care Enhancement Act of 2007

Sponsor: Mike Ross (D-Ark.)

S.2352: Medicare Hearing Health Care Enhancement Act of 2007

Sponsor: Tim Johnson (D-S.D.)

H.R.1823: Ambulatory Surgical Center Medicare Payment Modernization Act of 2007

Sponsor: Kendrick B. Meek (D-Fla.)

S.2250: Ambulatory Surgical Center Medicare Payment Modernization Act of 2007

Sponsor: Michael D. Crapo (R-Idaho)

H.R.1774: To amend title XVIII of the Social Security Act to establish a separate...

Sponsor: G. K. Butterfield (D-N.C.)

S.45: A bill to amend title XVIII of the Social Security Act to make a...

Sponsor: John Ensign (R-Nev.)

S.2785: Save Medicare Act of 2008

Sponsor: Debbie Stabenow (D-Mich.)

S.3101: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Max Baucus (D-Mont.)

S.3118: Preserving Access to Medicare Act of 2008

Sponsor: Charles E. Grassley (R-Iowa)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.2585: Ensuring the Future Physician Workforce Act of 2007

Sponsor: Michael C. Burgess (R-Texas)

S.2729: Ensuring the Future Physician Workforce Act of 2008

Sponsor: John Cornyn (R-Texas)

H.R.5445: To amend part B of title XVIII of the Social Security Act to increase...

Sponsor: Tom Price (R-Ga.)

H.R.2580: Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of...

Sponsor: Phil Gingrey (R-Ga.)

H.R.2497: Fair and Reliable Medical Justice Act

Sponsor: Jim Cooper (D-Tenn.)

H.R.1198: Early Hearing Detection and Intervention Act of 2008

Sponsor: Lois Capps (D-Calif.)

S.1069: Early Hearing Detection and Intervention Act of 2007

Sponsor: Olympia J. Snowe (R-Maine)

H.R.3043: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: David R. Obey (D-Wis.)

S.1710: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Tom Harkin (D-Iowa)

H.R.3928: Truth in Healthcare Marketing Act of 2017

Sponsor: Larry Bucshon (R-Ind.)

H.R.5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina...

Sponsor: Brian Fitzpatrick (R-Pa.)

S.204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina...

Sponsor: Ron Johnson (R-Wis.)

H.RES.740: Expressing support for the designation of March 3, 2018, as World...

Sponsor: David McKinley (R-W.Va.)

S.2575: Audiology Patient Choice Act of 2018

Sponsor: Elizabeth Warren (D-Mass.)

H.R.1892: Bipartisan Budget Act of 2018

Sponsor: John B. Larson (D-Conn.)

H.R.1876: Good Samaritan Health Professionals Act of 2017

Sponsor: Marsha Blackburn (R-Tenn.)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

H.R.6: SUPPORT for Patients and Communities Act

Sponsor: Greg Walden (R-Ore.)

S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

Sponsor: Richard M. Burr (R-N.C.)

H.R.6147: Interior, Environment, Financial Services and General Government,...

Sponsor: Ken Calvert (R-Calif.)

H.R.1120: Alice Cogswell and Anne Sullivan Macy Act

Sponsor: Matt Cartwright (D-Pa.)

H.RES.147: Expressing support for the designation of March 3, 2019, as World...

Sponsor: Mike Thompson (D-Calif.)

H.R.1763: Resident Physician Shortage Reduction Act of 2019

Sponsor: Terri Sewell (D-Ala.)

S.348: Resident Physician Shortage Reduction Act of 2019

Sponsor: Robert Menendez (D-N.J.)

H.R.2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act...

Sponsor: Frank Pallone (D-N.J.)

S.9: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Marco Rubio (R-Fla.)

H.R.1854: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act...

Sponsor: Kathy Castor (D-Fla.)

H.R.2328: Reauthorizing and Extending America’s Community Health Act

Sponsor: Tom O'Halleran (D-Ariz.)

S.1895: Lower Health Care Costs Act

Sponsor: Lamar Alexander (R-Tenn.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.4056: Medicare Audiologist Access and Services Act of 2019

Sponsor: Tom Rice (R-S.C.)

S.2446: Medicare Audiologist Access and Services Act of 2019

Sponsor: Elizabeth Warren (D-Mass.)

S.3449: TM Act of 2020

Sponsor: Thom Tillis (R-N.C.)

S.1350: Good Samaritan Health Professionals Act of 2019

Sponsor: Bill Cassidy (R-La.)

H.R.3502: Protecting People From Surprise Medical Bills Act

Sponsor: Raul Ruiz (D-Calif.)

S.1531: STOP Surprise Medical Bills Act of 2019

Sponsor: Bill Cassidy (R-La.)

H.R.3630: No Surprises Act

Sponsor: Frank Pallone (D-N.J.)

H.R.3107: Improving Seniors' Timely Access to Care Act of 2019

Sponsor: Suzan K. DelBene (D-Wash.)

H.R.7059: Coronavirus Provider Protection Act

Sponsor: Phil Roe (R-Tenn.)

H.R.663: Burn Pits Accountability Act

Sponsor: Tulsi Gabbard (D-Hawaii)

H.R.884: Medicare Mental Health Access Act

Sponsor: Judy Chu (D-Calif.)

S.2772: Medicare Mental Health Access Act

Sponsor: Sherrod Brown (D-Ohio)

S.4317: SAFE TO WORK Act

Sponsor: John Cornyn (R-Texas)

H.R.8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020

Sponsor: Ami Bera (D-Calif.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

H.R.1587: Medicare Audiologist Access and Services Act of 2021

Sponsor: Tom Rice (R-S.C.)

H.R.3173: Improving Seniors’ Timely Access to Care Act of 2021

Sponsor: Suzan K. DelBene (D-Wash.)

H.R.3021: Coronavirus Provider Protection Act

Sponsor: J. Luis Correa (D-Calif.)

S.1314: Tobacco Tax Equity Act of 2021

Sponsor: Richard J. Durbin (D-Ill.)

S.2941: Good Samaritan Health Professionals Act of 2021

Sponsor: Bill Cassidy (R-La.)

H.R.5239: Good Samaritan Health Professionals Act of 2021

Sponsor: Raul Ruiz (D-Calif.)

S.1731: Medicare Audiologist Access and Services Act of 2021

Sponsor: Elizabeth Warren (D-Mass.)

S.610: Protecting Medicare and American Farmers from Sequester Cuts Act

Sponsor: Tim Kaine (D-Va.)

H.R.1667: Dr. Lorna Breen Health Care Provider Protection Act

Sponsor: Susan Wild (D-Pa.)

H.R.6087: Improving Access to Workers’ Compensation for Injured Federal Workers Act

Sponsor: Joe Courtney (D-Conn.)

S.3018: Improving Seniors’ Timely Access to Care Act of 2021

Sponsor: Roger Marshall (R-Kan.)

H.R.5561: Early Hearing Detection and Intervention Act of 2021

Sponsor: Brett Guthrie (R-Ky.)

S.4052: Early Hearing Detection and Intervention Act of 2022

Sponsor: Rob Portman (R-Ohio)

H.R.8199: Magnet Injury Prevention Act

Sponsor: Tony Cárdenas (D-Calif.)

S.4479: Magnet Injury Prevention Act

Sponsor: Richard Blumenthal (D-Conn.)

H.R.8800: Supporting Medicare Providers Act of 2022

Sponsor: Ami Bera (D-Calif.)

H.R.7995: GOLD CARD Act of 2022

Sponsor: Michael C. Burgess (R-Texas)

H.R.8487: Improving Seniors’ Timely Access to Care Act of 2022

Sponsor: Suzan K. DelBene (D-Wash.)

H.R.9584: ACCESS Act of 2022

Sponsor: Richard Hudson (R-N.C.)

S.5194: Protecting Medicare Patients and Physicians Act

Sponsor: John Kennedy (R-La.)

H.R.8812: I CAN Act

Sponsor: Lucille Roybal-Allard (D-Calif.)

H.R.2474: Strengthening Medicare for Patients and Providers Act

Sponsor: Raul Ruiz (D-Calif.)

S.652: Safe Step Act

Sponsor: Lisa Murkowski (R-Alaska)

H.R.2630: Safe Step Act

Sponsor: Brad Wenstrup (R-Ohio)

S.1302: Resident Physician Shortage Reduction Act of 2023

Sponsor: Robert Menendez (D-N.J.)

H.R.2389: Resident Physician Shortage Reduction Act of 2023

Sponsor: Terri Sewell (D-Ala.)

H.R.4775: Helping Tobacco Users Quit Act

Sponsor: Lisa Blunt Rochester (D-Del.)

S.2377: Medicare Audiology Access Improvement Act of 2023

Sponsor: Elizabeth Warren (D-Mass.)

S.2733: PEER Support Act

Sponsor: Tim Kaine (D-Va.)

H.R.6445: Medicare Audiology Access Improvement Act of 2023

Sponsor: Gus Bilirakis (R-Fla.)

H.R.6683: Preserving Seniors’ Access to Physicians Act of 2023

Sponsor: Greg Murphy (R-N.C.)

H.R.766: Dr. Michael C. Burgess Preventive Health Savings Act

Sponsor: Michael C. Burgess (R-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist	Covered positions?
Joy Trimmer JD	Judiciary LA/Staff Counsel, Rep. Ed Pease (IN) Judiciary LA/Staff Counsel - Rep. Ed Pease (IN) Judiciary LA/ Staff Counsel, Rep. Ed Pease (IN) Judiciary LA/Staff Counsel, Rep. Ed. Pease (IN) Judiciary LA./Staff Counsel. Rep. Ed Pease (IN) Judiciary LA.Staff Counsel, Rep. Ed Pease (IN) Judiciary LA/Staff Counsel, Rep. Pease (IN) Judiciary LA/Staff Counsel. Rep. Ed Pease (IN) Senior Director
Joy Trimmer	Judiciary LA/Staff Counsel, Rep. Ed Pease (IN)
Erin LaFlair	Staff Assistant, Cmte on Ways and Means Staff Assisant, Cmte on Ways and Means Staff Assistant, Cmte. on Ways and Means Program Manager
Andrew Scholnick	Legislative Assistant
David Nielsen MD	CEO/EVP
Maura Farrell	Legislative Assistant, Representative George Radanovich, 2001-2003
Megan Marcinko	n/a
Amelia Suermann	n/a
Danielle Jarchow JD	n/a
Chelsea Ronayne	n/a
Megan Marinko	n/a
Andrew Scholick	n/a
Karl Melton	n/a
Michael Keegan	n/a
Ruth Hazdovac	n/a
Christopher Stewart	n/a
Thomas Radder	n/a
John Aguilar	n/a
Harry deCabo	n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

1st Quarter, 2024

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 22. Original Filing: 301572868.xml

Lobbying Issues

1/2/24 AAO-HNS letter to CMS on the agency's proposed rule on federal independent dispute resolution operations of the No Surprises Act. 1/8/24 Coalition letter to Administrator of the Centers for Medicare and Medicaid Services (CMS); includes issues relating to classification/coverage of prescription drugs and exchange network adequacy standards. 1/9/24 AAO-HNS led letter to House Energy & Commerce and Ways & Means Committees opposing the Medicare Audiology Access Improvement Act (H.R. 6445) 1/24/24 Coalition letter to leadership of the Senate HELP Committee opposing Section 5 of the "Health Care PRICE Transparency Act 2.0." Suggests pursuing alternative course of action to better support ASCs. 2/15/24 Coalition letter thanking members for reauthorizing the "Dr. Lorna Breen Health Care Provider Protection Act." Encourages members to continue supporting mental health services for healthcare professionals. 2/16/24 Letter to FDA; issues relating to public comment and FDA best practices. 3/1/24 Coalition letter to Director of the Center for Medicare at the Centers for Medicare and Medicaid Services (CMS); includes issues relating to network adequacy, the Star Ratings system, and prior authorization. 3/15/24 Letter to Chair and Ranking Member of House Committee on Education and the Workforce; Issues relating to prior authorization reform and administrative burden; including ERISA and H.R. 2630 (The Safe Step Act). 3/18/24 Letter to Reps. Michael Burgess and Diana DeGette offering the AAO-HNS' support of H.R. 766 (Dr. Michael C. Burgess Preventive Health Savings Act) and reform of the CBO scoring system. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to prior authorization, in general Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

1/9/24 Coalition to letter to Chairs and Ranking Members of the House and Senate Committees on Appropriations urging that appropriations for FY 2024 retain the FDA's authority to regulate tobacco products and do not cut funding from the CDC's Office on Smoking and Health (OSH). 3/25/24 Coalition letter to the Chair and Ranking Member of the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. 3/25/24 Coalition letter to the Chair and Ranking Member of the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

1/9/24 Coalition to letter to Chairs and Ranking Members of the House and Senate Committees on Appropriations urging that appropriations for FY 2024 retain the FDA's authority to regulate tobacco products and do not cut funding from the CDC's Office on Smoking and Health (OSH). 1/17/24 Coalition letter urging House and Senate leadership to reverse the 3.37% cut to Medicare physician payments that took effect on January 1st, 2024. 3/18/24 Letter to Reps. Michael Burgess and Diana DeGette offering the AAO-HNS' support of H.R. 766 (Dr. C Burgess Preventive Health Savings Act) and reform of the CBO scoring system. 3/25/24 Coalition letter to the Chair and Ranking Member of the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. 3/25/24 Coalition letter to the Chair and Ranking Member of the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. Issues pertaining to the budget and appropriations, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2023

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 18. Original Filing: 301528138.xml

Lobbying Issues

December 21, 2023 coalition letter to the Food and Drug Administration (FDA) on the issue of communications from firms to health care providers regarding scientific information on unapproved uses of approved/cleared medical products. December 20, 2023 letter led by the AAO-HNS and signed by 111 physician organizations to the Senate Finance Committee expressing strong opposition to the Medicare Audiology Access Improvement Act (S. 2377). November 30, 2023 coalition letter to the Medicare Payment Advisory Commission (MedPAC) on assessing and updating Medicare payment for physicians in calendar year 2025. November 16, 2023 coalition letter to Congressional Leadership urging them to pass legislation to prevent the pending 3.37% cut to Medicare physician payment that will go into effect in January 2024. October 31, 2023 coalition letter to Representatives Brad Wenstrup, Greg Murphy, and Michael Burgess in support of their legislative proposal to reform the budget-neutrality proposals that have been eroding Medicare physician payment. October 30, 2023 coalition letter to the House Energy and Commerce Committee and the Senate HELP Committee expressing concern about the Department of Health and Human Services recent proposed rule on nondiscrimination in health programs and activities. October 19, 2023 coalition letter to the House Energy and Commerce Committee providing feedback on legislation considered for its hearing entitled Whats the Prognosis? Examining Medicare Proposals to Improve Patient Access to Care and Minimize Red Tape for Doctors. October 15, 2023 coalition letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending. October 13, 2023 letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending. Issues pertaining to scope of practice legislation, related to the Medicare Audiology Access Improvement Act of 2023 (S. 2733 / H.R. 6445), and in general Issues pertaining to prior authorization, in general Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

December 20, 2023 letter led by the AAO-HNS and signed by 111 physician organizations to the Senate Finance Committee expressing strong opposition to the Medicare Audiology Access Improvement Act (S. 2377). November 30, 2023 coalition letter to the Medicare Payment Advisory Commission (MedPAC) on assessing and updating Medicare payment for physicians in calendar year 2025. November 16, 2023 coalition letter to Congressional Leadership urging them to pass legislation to prevent the pending 3.37% cut to Medicare physician payment that will go into effect in January 2024. October 31, 2023 coalition letter to Representatives Brad Wenstrup, Greg Murphy, and Michael Burgess in support of their legislative proposal to reform the budget-neutrality proposals that have been eroding Medicare physician payment. October 30, 2023 coalition letter to the House Energy and Commerce Committee and the Senate HELP Committee expressing concern about the Department of Health and Human Services recent proposed rule on nondiscrimination in health programs and activities. October 19, 2023 coalition letter to the House Energy and Commerce Committee providing feedback on legislation considered for its hearing entitled Whats the Prognosis? Examining Medicare Proposals to Improve Patient Access to Care and Minimize Red Tape for Doctors. October 15, 2023 coalition letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending. October 13, 2023 letter to the House Budget Committee in response to their Request for Information (RFI) on ways to improve health outcomes while reducing federal health care spending. Issues pertaining to scope of practice legislation, related to the Medicare Audiology Access Improvement Act of 2023 (S. 2733 / H.R. 6445), and in general Issues pertaining to prior authorization, in general Issues pertaining to the Early Hearing Detection and Intervention Program, in general Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2023

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2023. Original Filing: 301511567.xml

Lobbying Issues

August 17, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the agency's Request for Information on Episode-Based Payment Models expressing support for the agency's broad goal of providing enhanced patient care in the context of value-based reimbursement arrangements. August 30, 2023 comment letter regarding the Food and Drug Administration's Center for Devices and Radiological Healths (CDRH) search for input from the physician community on advancing health equity and facilitating access to medical devices designed to be safe and effective when used outside of traditional clinical settings such as the home setting. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure in response to the calendar year 2024 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. September 11, 2023 letter to CMS Administrator Chiquita Brooks-LaSure pertaining to the ambulatory surgical center payment update and updated APC classifications for various HCPCS codes. September 28, 2023 coalition letter to Representative Lisa Blunt Rochester and Representative Brian Fitzpatrick in support of H.R. 4775, the Helping Tobacco Users Quit Act, that will ensure that all Medicaid and Childrens Health Insurance Program enrollees have access to the full array of evidence-based tobacco cessation treatments, including all Food and Drug Administration medications. Issues pertaining to scope of practice legislation specifically related to opposition of S. 2377, the Medicare Audiology Access Improvement Act of 2023, and in general. Issues related to the support of the Safe Step Act (S. 652 / H.R. 2630) which would improve patient access by requiring insurance providers to implement a clear and transparent process for a patient or physician to request an exception to a step therapy protocol. Issues pertaining to prior authorization, in general. Issues pertaining to Medicare physician reimbursement related to H.R. 2474, the Strengthening Medicare for Patients and Providers Act, and in general. Issues related to hearing healthcare, in general. Issues pertaining to the implementation of the No Surprises Act. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2023

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2023. Original Filing: 301488053.xml

Lobbying Issues

April 7, 2023 coalition letter to HHS Deputy Assistance Secretary for the Office of Human Services Policy Miranda Lynch-Smith in response to their Request for Input (RFI) pertaining to improving care delivery and integrating specialty care in population-based models. April 24, 2023 coalition letter to Representatives Bucshon and Ruiz in support of their legislation H.R. 5239, the Good Samaritan Health Professionals Act of 2023, which would ensure that victims of federally declared disasters and public health emergencies have adequate access to medical care following a catastrophic event while protecting healthcare workers and volunteers. May 3, 2023 coalition letter to Senators Lisa Murkowski, Roger Marshall, Maggie Hassan, and Jacky Rosen in support of S. 652, the Safe Step Act, which would provide patients and providers with a clear and transparent appeals process when subject to step therapy protocols instituted by insurers. May 3, 2023 coalition letter to Representatives Brad Wenstrup and Raul Ruiz in support of H.R. 2630, The Safe Step Act, which would provide patients and providers with a clear and transparent appeals process when subject to step therapy protocols instituted by insurers. May 3, 2023 coalition letter to Representatives Raul Ruiz, Ami Bera, Larry Bucshon, and Marianette Miller-Meeks in support of their legislation H.R. 2474, The Strengthening Medicare for Patients and Providers Act, which would provide an annual inflationary update for Medicare physician payment tied to the Medicare Economic Index (MEI). May 3, 2023 coalition letter to Senators Bob Menendez, Chuck Schumer, John Boozman, and Susan Collins in support of their legislation S. 1302, the Resident Physician Shortage Reduction Act of 2023, which would increase the number of Graduate Medical Education residency positions in order to tackle the severe physician shortage. May 5, 2023 letter to the HHS Director of the Hospital and Ambulatory Policy Group Carol Blackford to request clarification on whether outpatient telehealth services provided to Medicare beneficiaries by facility-based speech-language pathologists (SLPs) will be covered after the end of the federally declared public health emergency (PHE) on May 11, 2023. May 8, 2023 coalition letter to Representatives Terri Sewell and Brian Fitzpatrick in support of their legislation H.R. 2389, the Resident Physician Shortage Reduction Act of 2023, which would increase the number of Graduate Medical Education residency positions in order to tackle the severe physician shortage. May 22, 2023 coalition letter to Senators Bob Menendez, Chuck Schumer, John Boozman, and Susan Collins in support of their legislation S. 1302, the Resident Physician Shortage Reduction Act of 2023, which would increase the number of Graduate Medical Education residency positions in order to tackle the severe physician shortage. May 23, 2023 coalition letter to Senators Richard Blumenthal, Gary Peters, Ron Johnson, and Rand Paul thanking them for their hearing examining health care denials and delays in Medicare Advantage particularly pertaining to the issues of prior authorization and utilization management. June 12, 2023 coalition letter to Representatives Kay Granger and Rosa DeLauro urging them to reject any efforts to narrow, weaken, or modify the Food and Drug Administrations current authority to oversee tobacco products during consideration of the FY 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill. June 20, 2023 coalition letter to National Coordinator for Health Information Technology Micky Tripathi providing feedback on issues pertaining to ONCs HT-1 proposed rule, development of CEHRT criteria, and prior authorization requirements. Issues pertaining to scope of practice legislation, in general. Issues pertaining to prior authorization, in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

May 3, 2023 coalition letter to Representatives Raul Ruiz, Ami Bera, Larry Bucshon, and Marianette Miller-Meeks in support of their legislation H.R. 2474, The Strengthening Medicare for Patients and Providers Act, which would provide an annual inflationary update for Medicare physician payment tied to the Medicare Economic Index (MEI). May 5, 2023 letter to the HHS Director of the Hospital and Ambulatory Policy Group Carol Blackford to request clarification on whether outpatient telehealth services provided to Medicare beneficiaries by facility-based speech-language pathologists (SLPs) will be covered after the end of the federally declared public health emergency (PHE) on May 11, 2023. May 23, 2023 coalition letter to Senators Richard Blumenthal, Gary Peters, Ron Johnson, and Rand Paul thanking them for their hearing examining health care denials and delays in Medicare Advantage particularly pertaining to the issues of prior authorization and utilization management. Issues pertaining to scope of practice legislation, in general. Issues pertaining to prior authorization, in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2023

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2023. Original Filing: 301464498.xml

Lobbying Issues

January 23, 2023 coalition letter to all Members of the House and Senate urging Congress to hold hearings and work with stakeholders to enact a long-term fix to the Medicare physician payment system. January 30, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure expressing ongoing concern with network adequacy in Marketplace plans and other issues including Part 156. February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on the proposed policy changes for Medicare Advantage Organizations and their impacts on access to specialty care. February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure urging CMS to finalize improvement of the coverage criteria used in medical necessity determinations, ensure a clinically sound foundation for Prior Authorization programs, and protect access to care. February 21, 2023 coalition letter to all members of the House and Senate expressing support for proposed rules the Food and Drug Administration has issued to prohibit manufacture and sale of menthol cigarettes and flavored cigars. March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on proposed policy changes to advance interoperability and improve prior authorization. March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure commenting on the Notice of Proposed Rulemaking outlining proposals to advance interoperability and improve prior authorization in Medicare Advantage plans, state Medicaid agencies and Medicaid managed care plans, CHIP agencies, and issuers of Qualified Health Plans on Federally Facilitated Exchanges. March 15, 2023 coalition letter to Speaker Kevin McCarthy, Minority Leader Hakeem Jeffries, Majority Leader Chuck Schumer, and Minority Leader Mitch McConnell urging Congress to provide an annual inflation-based payment update based on the full Medicare Economic Index. March 16, 2023 coalition letter to Rep. Robert Aderholt and Rep. Rosa DeLauro urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million. March 16, 2023 coalition letter to Senator Tammy Baldwin and Senator Shelley Moore-Capito urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million. March 20, 2023 coalition letter to Senator Bernie Sanders and Senator Bill Cassidy providing information related to the drivers of health care workforce shortages and potential solutions to such shortages. March 29, 2023 coalition letter to Senator Bernie Sanders, Senator Bob Casey, Senator Bill Cassidy, and Senator Mitt Romney urging them to ensure Federal law provides medical service volunteers who cross state lines to assist with the response to a national emergency, major disaster, or a public health emergency with adequate protection as provided in the bipartisan Good Samaritan Health Professionals Act. Issues pertaining to scope of practice legislation, in general. Issues pertaining to prior authorization, in general. Issues pertaining to the Early Hearing Detection and Intervention Program, in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

February 21, 2023 coalition letter to all members of the House and Senate expressing support for proposed rules the Food and Drug Administration has issued to prohibit manufacture and sale of menthol cigarettes and flavored cigars. March 16, 2023 coalition letter to Rep. Robert Aderholt and Rep. Rosa DeLauro urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million. March 16, 2023 coalition letter to Senator Tammy Baldwin and Senator Shelley Moore-Capito urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million. Issues pertaining to tobacco control, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2022

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2023. Original Filing: 301440871.xml

Lobbying Issues

December 22, 2022, Alliance of Specialty Medicine letter to Representative Richard Hudson expressing our support for H.R. 9584, the Accessible Care by Curbing Excessive lawSuitS Act of 2022, which sets conditions for lawsuits arising from health care liability claims. December 21, 2022, Alliance of Specialty Medicine letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell expressing our concern about pending cuts to Medicare physician payment rates in the Fiscal Year 2023 Omnibus Appropriations bill. December 20, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, Senate Republican Leader Mitch McConnell, Senators Ron Wyden and Mike Crapo, and Representatives Frank Pallone and Cathy McMorris Rodgers, urging Congress to modify the omnibus legislation and stop the full 4.5 percent cut to Medicare physician payment rates for Fiscal Year 2023. December 16, 2022, Alliance of Specialty Medicine letter to Senator John Kennedy expressing our support for S. 5194, the Protecting Medicare Patients and Physicians Act, which would mitigate pending cuts to Medicare physician payment rates in Fiscal Year 2023. December 6, 2022, Alliance of Specialty Medicine letter to Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure in response to CMS request for information (RFI) soliciting public comment on establishing a National Directory of Healthcare Providers & Services (NDH). December 5, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell urging Congress to prevent the entire 4.5 percent reduction to Medicare physician payment rates from being implemented on January 1, 2023. November 21, 2022, coalition letter to Federal Trade Commission (FTC) Chair Lina Khan commenting on the FTCs advance notice of proposed rulemaking (ANPR) entitled Trade Regulation Rule on Commercial Surveillance and Data Security, which pertains to clinical data registries. November 2, 2022, coalition letter to Representatives Richard Neal, Kevin Brady, Frank Pallone, Cathy McMorris Rodgers, Lucille Roybal-Allard and David Joyce expressing our opposition to H.R. 8812, the Improving Care and Access to Nurses Act or the I CAN Act. This legislation would expand the scope of practice for non-physician practitioners (NPPs) under Medicare and Medicaid. October 31, 2022, coalition letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). October 28, 2022, letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, H.R. 8812, H.R. 6087, and in general. Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general. Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 8800 and S. 5194, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues pertaining to healthcare liability reform, related to H.R. 9584, and in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation. Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479. Issues pertaining to clinical data registries, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

December 21, 2022, Alliance of Specialty Medicine letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell expressing our concern about pending cuts to Medicare physician payment rates in the Fiscal Year 2023 Omnibus Appropriations bill. December 20, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, Senate Republican Leader Mitch McConnell, Senators Ron Wyden and Mike Crapo, and Representatives Frank Pallone and Cathy McMorris Rodgers, urging Congress to modify the omnibus legislation and stop the full 4.5 percent cut to Medicare physician payment rates for Fiscal Year 2023. December 16, 2022, Alliance of Specialty Medicine letter to Senator John Kennedy expressing our support for S. 5194, the Protecting Medicare Patients and Physicians Act, which would mitigate pending cuts to Medicare physician payment rates in Fiscal Year 2023. December 6, 2022, Alliance of Specialty Medicine letter to Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure in response to CMS request for information (RFI) soliciting public comment on establishing a National Directory of Healthcare Providers & Services (NDH). December 5, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell urging Congress to prevent the entire 4.5 percent reduction to Medicare physician payment rates from being implemented on January 1, 2023. November 2, 2022, coalition letter to Representatives Richard Neal, Kevin Brady, Frank Pallone, Cathy McMorris Rodgers, Lucille Roybal-Allard and David Joyce expressing our opposition to H.R. 8812, the Improving Care and Access to Nurses Act or the I CAN Act. This legislation would expand the scope of practice for non-physician practitioners (NPPs) under Medicare and Medicaid. October 31, 2022, coalition letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). October 28, 2022, letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, H.R. 8812, and in general. Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general. Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, S. 5194, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to COVID-19, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2022

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2022. Original Filing: 301417050.xml

Lobbying Issues

September 30, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 29, 2022, Alliance of Specialty Medicine letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 28, 2022, letter to FDA Commissioner Califf expressing concern regarding the ongoing national shortage of tracheostomy tubes for pediatric and adult patients. September 22, 2022, coalition letter to Speaker Pelosi, Leader McCarthy, Leader Schumer, and Leader McConnell warning about the impact of scheduled cuts to Medicare reimbursement for physicians and asking Congress to take action on overall reform for Medicare payment. September 14, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 6, 2022, coalition letter to CMS Administrator Brooks-LaSure expressing concerns with the Medicare Physician Fee Schedule global surgical package. August 1, 2022, Alliance of Specialty Medicine coalition letter to HHS Assistant Secretary Levine responding to the "Request for Information (RFI): HHS Initiative To Strengthen Primary Health Care." July 28, 2022, Alliance of Specialty Medicine letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program). July 27, 2022, coalition letter to congressional leadership for the Senate Finance, House Ways and Means, and House Energy and Commerce committees regarding concerns over scheduled cuts to Medicare reimbursement rates for physicians. July 18, 2022, coalition letter to Senate Majority Leader Schumer and Speaker Pelosi urging investment in the healthcare workforce and robust funding for Graduate Medical Education (GME). July 18, 2022, letter to Sandra Battiste, MPH, of the Health Resources & Services Administration, responding to the Request for Information: Early Hearing Detection and Intervention Program. July 7, 2022, Physician Clinical Registry Coalition letter to Michelle Schreiber, MD, Deputy Director of the Centers for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS), expressing concerns with the measure set review (MSR) process. July 6, 2022, letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program). Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731 and H.R. 6087, and in general. Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general. Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation. Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479.

Agencies Lobbied

Type of Issue

Lobbying Issues

September 30, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 29, 2022, Alliance of Specialty Medicine letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 22, 2022, coalition letter to Speaker Pelosi, Leader McCarthy, Leader Schumer, and Leader McConnell warning about the impact of scheduled cuts to Medicare reimbursement for physicians and asking Congress to take action on overall reform for Medicare payment. September 14, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians). September 6, 2022, coalition letter to CMS Administrator Brooks-LaSure expressing concerns with the Medicare Physician Fee Schedule global surgical package. July 28, 2022, Alliance of Specialty Medicine letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program). July 27, 2022, coalition letter to congressional leadership for the Senate Finance, House Ways and Means, and House Energy and Commerce committees regarding concerns over scheduled cuts to Medicare reimbursement rates for physicians. July 18, 2022, coalition letter to Senate Majority Leader Schumer and Speaker Pelosi urging investment in the healthcare workforce and robust funding for Graduate Medical Education (GME). July 7, 2022, Physician Clinical Registry Coalition letter to Michelle Schreiber, MD, Deputy Director of the Centers for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS), expressing concerns with the measure set review (MSR) process. July 6, 2022, letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program). Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general. Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general. Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general. Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, and in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to COVID-19, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2022

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2022. Original Filing: 301389854.xml

Lobbying Issues

May 17, 2022, coalition comments addressed to the Federal Trade Commission regarding the pharmacy benefit manager (PBM) industry. June 7, 2022, letter to Speaker Pelosi and Leader McCarthy expressing opposition to H.R. 6087, the "Improving Access to Workers' Compensation for Injured Federal Workers Act." Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general. Issues pertaining to prior authorization, related to H.R. 3173/S. 3018, and in general. Issues pertaining to the Early Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation. Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479.

Agencies Lobbied

Type of Issue

Lobbying Issues

May 18, 2022, coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure on the importance of the Appropriate Use Criteria (AUC) Program and requesting ample opportunity for stakeholder engagement with CMS. June 27, 2022, coalition letter addressed to Chairs DeGette and Pallone, and Ranking Members Griffith and McMorris Rodgers, expressing support for H.R. 3173 and reforming the prior authorization process in the Medicare Advantage program. Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general. Issues pertaining to prior authorization, related to H.R. 3173/S. 3018, and in general. Issues pertaining to Medicare physician reimbursement, in general Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

April 18, 2022, coalition letter addressed to Chair DeLauro and Ranking Member Cole advocating for increasing funding for the CDC Office on Smoking Health by $68.5 million in the FY2023 Labor, Health and Human Services, Education and Related Agencies Appropriations bill. April 18, 2022, coalition letter addressed to Chair Murray and Ranking Member Blunt advocating for increasing funding for the CDC Office on Smoking Health by $68.5 million in the FY2023 Labor, Health and Human Services, Education and Related Agencies Appropriations bill. June 14, 2022, coalition letter addressed to Chair Bishop and Ranking Member Harris advocating that the FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill not include provisions that would weaken FDA's authority over tobacco products. Issues pertaining to tobacco control, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2022

Amendment

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY amended a lobbying report for in-house lobbying in Q12022 on May 27, 2022 Original Filing: 301375768.xml

Lobbying Issues

Coalition letter addressed to Senators Patty Murray and Richard Burr, urging the Senate to reauthorize the Early Hearing Detection and Intervention (EHDI) program. Coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure urging CMS not to disrupt team-based care in the facility setting and to revise the split or shared visit policy to allow the physician or QHP who is managing and overseeing the patients care to bill for the service. Coalition letter addressed to HRSA Administrator Carole Johnson asking that HRSA reopen the Period 1 reporting window for Provider Relief Funding for at least 60 days and engage in a targeted campaign to reach those who have yet to comply. Coalition letter addressed to Senators Kaine and Young and Representatives Wild and McKinley thanking them for introducing the Dr. Lorna Breen Health Care Provider Protection Act (S. 610/H.R. 1667). Coalition letter addressed to FDA Commissioner Robert Califf asking the FDA to work with stakeholders in educating consumers to consult with their health care providers to determine whether OTC hearing devices will be a quality option for them. Coalition letter requesting information from Dr. Micky Tripathi regarding electronic prior authorization standards, implementation specifications, and certification criteria. Specifically, the letter requests that ONC and CMS adopt the electric prior authorization process. Coalition letter addressed to CMS Director Dr. Meena Seshamani requesting that MA plans follow a standardized process for all medical record requests using a secure online portal. In addition, the letter requests the CMS establish a stars measure that would aware points to MA plans that maintain an adequate network of specialty physicians, including those that participate in the QPP. A coalition letter addressed to Chairs and Ranking Members of the Senate Finance Committee, House Ways and Means Committee, and House Energy and Commerce Committee requesting that the committees collaborate with the provider community to immediately initiate formal proceedings (hearing, roundtables, expert panels, etc.) to discuss potential reforms to the Medicare physician payment system to ensure continued beneficiary access to care. Issues pertaining to the scope of practice legislation, in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to the Early Detection and Intervention Program, in general. Issues pertaining to COVID-19, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure urging CMS not to disrupt team-based care in the facility setting and to revise the split or shared visit policy to allow the physician or QHP who is managing and overseeing the patients care to bill for the service. Coalition letter addressed to Chairs and Ranking Members of the Senate Finance Committee, House Ways and Means Committee, and House Energy and Commerce Committee urging them to hold hearings on the future of the Medicare physician fee schedule and the status of other policies included in the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including the Quality Payment Program. Coalition letter addressed to HRSA Administrator Carole Johnson asking that HRSA reopen the Period 1 reporting window for Provider Relief Funding for at least 60 days and engage in a targeted campaign to reach those who have yet to comply. Coalition letter addressed to Senators Kaine and Young and Representatives Wild and McKinley thanking them for introducing the Dr. Lorna Breen Health Care Provider Protection Act (S. 610/H.R. 1667). Coalition letter addressed to CMS Director Dr. Meena Seshamani requesting that MA plans follow a standardized process for all medical record requests using a secure online portal. In addition, the letter requests the CMS establish a stars measure that would aware points to MA plans that maintain an adequate network of specialty physicians, including those that participate in the QPP. Issues pertaining to the scope of practice legislation, in general. Issues pertaining to Medicare physician reimbursement, in general Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to the Early Detection and Intervention Program, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to COVID-19, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2022

Amendment

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY amended a lobbying report for in-house lobbying in Q12022 on May 27, 2022 Original Filing: 301375769.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2022

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2022. Original Filing: 301368730.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2021

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2022. Original Filing: 301335668.xml

Lobbying Issues

Letter addressed to Chiquita Brooks-LaSure, Administrator of the Centers for Medicare & Medicaid Services, urging the Biden administration to issue guidance that affirms physicians rights to choose to receive basic EFT payments without paying for additional services and undertaking the associate enforcement actions. Letter addressed to Janet Yellen, Secretary of the Treasury, Martin Walsh, Secretary of Labor, and Xavier Bacerra, Secretary of Health and Human Services requesting that the Departments remove the directive to the IDR entities to anchor their payment determination to the QPA, and revise the regulations to be consistent with Congressional intent. Letter addressed to Speaker of the House Nancy Pelosi, Minority Leader Kevin McCarthy, Senate Majority Leader Chuck Schumer, and Senate Minority Leader Mitch McConnell urging them to extend the Medicare Payment Fee Schedule 3.75% pay adjustment from 2021 through at least calendar year 2022. Letter addressed to Representatitves Diana DeGette and Fred Upton strongly supporting sections 309 and 411 of the Cures 2.0 Act. Letter addressed to Speaker of the House Nancy Pelosi, Minority Leader Kevin McCarthy, Senate Majority Leader Chuck Schumer, and Senate Minority Leader Mitch McConnell urging Congress to pass the Protecting Medicare and American Farmers from Sequester Cuts Act to mitigate the 2022 Medicare payment cuts. Letter addressed to Secretary of the Department of Veterans Affairs Denis McDonough urging the VA to establish a transparent process to allow internal and external stakeholder involvement in the VA Supremacy Project as early as possible. H.R. 1587, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general. Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better legislation.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2021

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2021. Original Filing: 301311126.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Letter address to Senators Cassidy and King, thanking them for introducing S. 2941, the Good Samaritan Health Professionals Act of 2021, which would increase liability protection for physicians who volunteer as emergency medical responders in the event of national calamities. Letter address to Representatives Ruiz and Bucshon, thanking them for introducing H.R. 5239, the Good Samaritan Health Professionals Act of 2021, which would increase liability protection for physicians who volunteer as emergency medical responders in the event of national calamities. Letter addressed to Senators Murray and Blunt, and Representatives DeLauro and Cole, expressing support for inclusion of hearing health provisions in FY22 Labor-HHS-Education appropriations bill. Letter addressed to Representatives DeGette and Upton with recommendations from the Physician Clinical Registry Coalition for the potential Cures 2.0 legislative package. Letter addressed to Secretaries Becerra, Walsh, and Yellen regarding the interim final rules regarding surprise billing. Letter addressed to Richard Landen and Denise Love, Co-Charis of the National Committee on Vital and Health Statistics (NCVHS) Subcommittee on Standards, supporting the NCVHS's efforts to enhance the exchange of clinical and administrative data through their recommendations to the Secretary. H.R. 1587, S. 1731, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Letter addressed to Representative Tim Ryan thanking him for including language in the FY22 Labor-HHS-Education appropriations bill report requesting a report from CMS on the implementation of the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. Letter addressed to Speaker Pelosi, Leader McCarthy, Majority Leader Schumer, and Minority Leader McConnell regarding mitigating potential future cuts within the Medicare Physician Fee Schedule. Letter addressed to Administrator Brooks-LaSure regarding office/outpatient visit E/M codes. Letter addressed to Senators Wyden and Crapo regarding opposition to S. 1731, the Medicare Audiologist Access and Services Act of 2021. H.R. 1587, S. 1731, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

2nd Quarter, 2021

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2021. Original Filing: 301285419.xml

Lobbying Issues

Letter addressed to Reps. Kelly, Buchshon, DelBene, and Bera strongly endorsing H.R. 3173, the Improving Seniors Timely Access to Care Act. Letter addressed to the Chairmen and Ranking Members of the House Committee on Ways and Means and the House Committee on Energy and Commerce strongly opposing H.R. 1587, the Medicare Audiologist Access and Services Act. Letter addressed to Elizabeth Richter, Acting Administrator of the Centers for Medicare & Medicaid Services, asking that CMS immediately release the 2018, 2019, and 2020 MIPS cost measures benchmarks. Coalition letter to Chiquita Brooks-LaSure, Administrator of the Centers for Medicare & Medicaid Services, urging CMS to finalize the Alternative 2 methodology in the FY 2022 Inpatient Prospective Payment System (IPPS) proposed rule, with modifications, and increase the number of full time equivalent (FTE) slots awarded per hospital for FY 2023 and all succeeding years. H.R. 1587, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Letter addressed to Reps. Kelly, Buchshon, DelBene, and Bera strongly endorsing H.R. 3173, the Improving Seniors Timely Access to Care Act. Letter addressed to the Chairmen and Ranking Members of the House Committee on Ways and Means and the House Committee on Energy and Commerce strongly opposing H.R. 1587, the Medicare Audiologist Access and Services Act. Letter addressed to Reps. Correa and Burgess strongly endorsing H.R. 3021, the Coronavirus Provider Protection Act. Letter addressed to Senators Coons and Graham, and Reps. Lee and Rogers, supporting inclusion of $100 million for Neglected Surgical Conditions within the State, Foreign Operations, and Related Programs Appropriations Report for FY 2022. Coalition letter to Chiquita Brooks-LaSure, Administrator of the Centers for Medicare & Medicaid Services, urging CMS to finalize the Alternative 2 methodology in the FY 2022 Inpatient Prospective Payment System (IPPS) proposed rule, with modifications, and increase the number of full time equivalent (FTE) slots awarded per hospital for FY 2023 and all succeeding years. H.R. 1587, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

1st Quarter, 2021

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2021. Original Filing: 301264687.xml

Lobbying Issues

Coalition letter to Karen Sanders, MD, the Acting Chief Academic Affiliations officer at the Department of Veterans Affairs requesting a meeting to discuss the impacts of the COVID-19 pandemic on surgical resident training. Coalition letter addressed to Elizabeth Richter, Acting Administrator of the Centers for Medicare & Medicaid Services(CMS) encouraging CMS to reduce the complexity of of the Merit-based Incentive Payment System(MIPS) Value Pathway(MVP) program, and strongly opposing the retiring of the traditional MIPS program by making MVPs mandatory. Coalition letter strongly urging the House of Representatives to reverse payment cuts to providers set to take effect under the 2021 Medicare Physician Fee Schedule during the 117th Congress. Coalition letter strongly urging the Senate to reverse payment cuts to providers set to take effect under the 2021 Medicare Physician Fee Schedule during the 117th Congress. Coalition letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, and Senate Minority Leader Mitch McConnell urging Congress to pass legislation to extend the congressionally enacted moratorium on Medicare sequester cuts through the duration of the public health emergency. Coalition letter addressed to Representatives Richard Neal, Frank Pallone, and Kevin Brady thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. Coalition letter addressed to Senators Ron Wyden and Chuck Grassley, thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. Coalition letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, and Senate Minority Leader Mitch McConnell, thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. H.R. 1587, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter to Karen Sanders, MD, the Acting Chief Academic Affiliations officer at the Department of Veterans Affairs requesting a meeting to discuss the impacts of the COVID-19 pandemic on surgical resident training. Coalition letter addressed to Elizabeth Richter, Acting Administrator of the Centers for Medicare & Medicaid Services(CMS) encouraging CMS to reduce the complexity of of the Merit-based Incentive Payment System(MIPS) Value Pathway(MVP) program, and strongly opposing the retiring of the traditional MIPS program by making MVPs mandatory. Coalition letter strongly urging the House of Representatives to reverse payment cuts to providers set to take effect under the 2021 Medicare Physician Fee Schedule during the 117th Congress. Coalition letter strongly urging the Senate to reverse payment cuts to providers set to take effect under the 2021 Medicare Physician Fee Schedule during the 117th Congress. Coalition letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, and Senate Minority Leader Mitch McConnell urging Congress to pass legislation to extend the congressionally enacted moratorium on Medicare sequester cuts through the duration of the public health emergency. Coalition letter addressed to Representatives Richard Neal, Frank Pallone, and Kevin Brady thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. Coalition letter addressed to Senators Ron Wyden and Chuck Grassley, thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. Coalition letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, and Senate Minority Leader Mitch McConnell, thanking them for including 1,000 new Medicare-supported graduate medical education positions in the Consolidated Appropriations Act of 2021. Coalition letter addressed to Robert Wilkie, Secretary of the Department of Veterans Affairs, opposing the interim final rule entitled "Authority of VA Professionals to Practice Health Care", which permits virtually all VHA-employed non-physician providers to practice without the clinical supervision of physicians and without regard to state scope of practice law. H.R. 1587, the "Medicare Audiologist Access and Services Act" all provisions. Issues pertaining to scope of practice legislation; in general. Issues pertaining to Medicare physician reimbursement, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2020

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2021. Original Filing: 301240763.xml

Lobbying Issues

Coalition letter to the Centers for Medicare and Medicaid Services (CMS) urging the retraction or postponement of the requirement that Qualified Clinical Data Registries (QCDRs) perform mandatory randomized audits for the MIPS Improvement Activities and Promoting Interoperability categories prior to CMS data submission. Coalition letter addressed to Senator Joe Manchin urging the inclusion of S. 4317, the "Safeguarding America's Frontline Employees to Offer Work Opportunities Required to Kickstart the Economy Act", in any COVID-19 relief packages. S. 4317 would provide liability protections to healthcare workers and facilities. Coalition letter addressed to Seema Verma, CMS Administrator, urging the Agency to reconsider the stand-alone Medicare Appropriate Use Criteria Program for advanced diagnostic imaging for its necessity and value. Letter to the House Minority Leader, Kevin McCarthy urging appointment of Congressman Michael Burgess as Ranking Member on the House Energy and Commerce Committee. Coalition letter addressed to Representatives Ami Bera, M.D., Larry Bucshon, M.D., Brendan Boyle, George Holding, Raul Ruiz, Phil Roe, Abby Finkenauer, and Roger Marshall, M.D. thanking them for the introduction of H.R. 8702 the "Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020" which would provide two years of Medicare payment updates. Letter addressed to Representatives Ami Bera, M.D., Larry Bucshon, M.D., Brendan Boyle, George Holding, Raul Ruiz, Phil Roe, Abby Finkenauer, and Roger Marshall, M.D. thanking them for introducing H.R. 8702 the "Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020" which would provide two years of Medicare payment updates. Coalition letter addressed to Seema Verma, CMS Administrator, urging the immediate implementation of and payment for Current Procedural Terminology code 99072 to compensate practices for the additional supplies and new staff activities required to provide safe patient care during the COVID-19 public health emergency. Letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Mitch McConnell, and Senate Minority Leader Charles Schumer urging amendments to the proposed "No Surprises Act" to resolve potential negative impacts on physicians. Coalition letter addressed to Stephen Hahn, Commissioner of the Food and Drug Administration, urging the prohibition of menthol as a characterizing flavor in cigarettes. Coalition letter addressed to Senator Charles Grassley, Senator Ron Wyden, Representatives Richard Neal, Kevin Brady, Frank Pallone, and Greg Walden urging Congress to pass a statutory delay of the Appropriate Use Criteria Program originally established in the 2014 Protecting Access to Medicare Act to allow for a thorough re-examination of the program. S. 4317, the Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act: COVID-19-related medical liability protections. H.R. 133, Consolidated Appropriations Act, 2021. No bill: Compromise legislation to provide protections for health insurance consumers from surprise medical bills. H.R. 663, the "Truth in Healthcare Marketing Act of 2020," all provisions. H.R. 7059, the Coronavirus Provider Protection Act," all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act" all provisions. H.R. 3502, the "Protecting People from Surprise Medical Bills Act," all provisions. S. 1531, the "STOP Surprise Medical Bills Act," to amend the Public Health Service Act to provide protections to health insurance consumers from surprise billing, all provisions. S. 1895, the "Lower Health Care Costs Act," to lower health care costs, all provisions. H.R. 3630, the "No Surprises Act," to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter to the Centers for Medicare and Medicaid Services (CMS) urging the retraction or postponement of the requirement that the Qualified Clinical Data Registries (QCDRs) perform mandatory randomized audits for the MIPS Improvement Activities and Promoting Interoperability categories prior to CMS data submission. Coalition letter addressed to Seema Verma, CMS Administrator, urging the Agency to reconsider the stand-alone Medicare Appropriate Use Criteria Program for advanced diagnostic imaging for its necessity and value as it is void of integration with patient quality, and outcomes and satisfaction metrics. Coalition letter addressed to Representatives Ami Bera, M.D., Larry Bucshon, M.D., Brendan Boyle, George Holding, Raul Ruiz, Phil Roe, Abby Finkenauer, and Roger Marshall, M.D. thanking them for the introduction of H.R. 8702 the "Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020" which would provide two years of Medicare payment updates. Letter addressed to Representatives Ami Bera, M.D., Larry Bucshon, M.D., Brendan Boyle, George Holding, Raul Ruiz, Phil Roe, Abby Finkenauer, and Roger Marshall, M.D. thanking them for the introduction of H.R. 8702 the "Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020" which would provide two years of Medicare payment updates. Coalition letter address to Seema Verma, CMS Administrator, urging the immediate implementation of and payment for Current Procedural Terminology code 99072 to compensate practices for the additional supplies and new staff activities required to provide safe patient care during the COVID-19 public health emergency. Letter addressed to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Mitch McConnell, and Senate Minority Leader Charles Schumer urging amendments to the proposed "No Surprises Act" to resolve potential negative impacts on physicians. Coalition letter addressed to Senator Charles Grassley, Senator Ron Wyden, Representatives Richard Neal, Kevin Brady, Frank Pallone, and Greg Walden urging Congress to pass a statutory delay of the Appropriate Use Criteria Program originally established in the 2014 Protecting Access to Medicare Act to allow for a thorough re-examination of the program. S. 4317, the Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act: COVID-19-related medical liability protections. H.R. 133, Consolidated Appropriations Act, 2021. No bill: Compromise legislation to provide protections for health insurance consumers from surprise medical bills. H.R. 3107, the "Improving Senior Timely Access to Care Act," to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes, all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act" all provisions. H.R. 3502, the "Protecting People from Surprise Medical Bills Act," all provisions. S. 1531, the "STOP Surprise Medical Bills Act," to amend the Public Health Service Act to provide protections to health insurance consumers from surprise billing, all provisions. S. 1895, the "Lower Health Care Costs Act," to lower health care costs, all provisions. H.R. 3630, the "No Surprises Act," to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2020

Amendment

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY amended a lobbying report for in-house lobbying in Q32020 on Oct. 20, 2020 Original Filing: 301222110.xml

Lobbying Issues

Coalition letter addressed to the Administrator for the Centers for Medicare and Medicaid Services urging CMS to sunset waivers involving scope of practice and licensure when the COVID public health emergency concludes. Coalition letter addressed to Speaker Nancy Pelosi, Leader Kevin McCarthy, Majority Leader Mitch McConnell, and Ranking Member Charles Schumer asking that unanticipated medical bills be addressed separately from any upcoming COVID-19 relief legislation. Coalition letter addressed to Chairman Frank Pallone, Ranking Member Greg Walden, Chairman Richard Neal, Ranking Member Kevin Brady, Chairman Chuck Grassley and Ranking Member Ron Wyden urging opposition to H.R. 884 / S. 2772, the Medicare Mental Health Access Act, which would decrease the overall access and quality of care for Medicare beneficiaries by inappropriately allowing psychologists to provide services well beyond their education and training. H.R. 663, the "Truth in Healthcare Marketing Act of 2020," all provisions. H.R. 7059, the Coronavirus Provider Protection Act," all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act" all provisions. H.R. 3502, the "Protecting People from Surprise Medical Bills Act," all provisions. S. 1531, the "STOP Surprise Medical Bills Act," to amend the Public Health Service Act to provide protections to health insurance consumers from surprise billing, all provisions. S. 1895, the "Lower Health Care Costs Act," to lower health care costs, all provisions. H.R. 3630, the "No Surprises Act," to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Administrator for the Centers for Medicare and Medicaid Services urging CMS to sunset waivers involving scope of practice and licensure when the COVID public health emergency concludes. Coalition letter addressed to Speaker Nancy Pelosi, Leader Kevin McCarthy, Majority Leader Mitch McConnell, and Ranking Member Charles Schumer asking that unanticipated medical bills be addressed separately from any upcoming COVID-19 relief legislation. Coalition letter addressed to Chairman Frank Pallone, Ranking Member Greg Walden, Chairman Richard Neal, Ranking Member Kevin Brady, Chairman Chuck Grassley and Ranking Member Ron Wyden urging opposition to H.R. 884 / S. 2772, the Medicare Mental Health Access Act, which would decrease the overall access and quality of care for Medicare beneficiaries by inappropriately allowing psychologists to provide services well beyond their education and training. H.R. 3107, the "Improving Senior Timely Access to Care Act," to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes, all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act" all provisions. H.R. 3502, the "Protecting People from Surprise Medical Bills Act," all provisions. S. 1531, the "STOP Surprise Medical Bills Act," to amend the Public Health Service Act to provide protections to health insurance consumers from surprise billing, all provisions. S. 1895, the "Lower Health Care Costs Act," to lower health care costs, all provisions. H.R. 3630, the "No Surprises Act," to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2020

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2020. Original Filing: 301220076.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Administrator for the Centers for Medicare and Medicaid Services urging CMS to sunset waivers involving scope of practice and licensure when the COVID public health emergency concludes. Coalition letter addressed to Speaker Nancy Pelosi, Leader Kevin McCarthy, Majority Leader Mitch McConnell, and Ranking Member Charles Schumer asking that unanticipated medical bills be addressed separately from any upcoming COVID-19 relief legislation. Coalition letter addressed to Chairman Frank Pallone, Ranking Member Greg Walden, Chairman Richard Neal, Ranking Member Kevin Brady, Chairman Chuck Grassley and Ranking Member Ron Wyden urging opposition to H.R. 884 / S. 2772, the Medicare Mental Health Access Act, which would decrease the overall access and quality of care for Medicare beneficiaries by inappropriately allowing psychologists to provide services well beyond their education and training. H.R. 3107, the "Improving Senior Timely Access to Care Act," to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes, all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act" all provisions. H.R. 3502, the "Protecting People from Surprise Medical Bills Act," all provisions. S. 1531, the "STOP Surprise Medical Bills Act," to amend the Public Health Service Act to provide protections to health insurance consumers from surprise billing, all provisions. S. 1895, the "Lower Health Care Costs Act," to lower health care costs, all provisions. H.R. 3630, the "No Surprises Act," to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2020

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2020. Original Filing: 301198201.xml

Lobbying Issues

Coalition letter addressed to the Secretary of the U.S. Department of Health and Human Services urging HHS to provide one month of revenue to each physician, nurse practitioner, and physician assistant enrolled in Medicare or Medicaid to account for financial losses and non-reimbursable expenses. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions such as student loan relief, medical liability protections, supply chain support and others in a future COVID-19 legislative package. Coalition letter addressed to Quality Measurement and Value-Based Incentives Group urging CMS to encourage clinicians and groups to report under the Merit-Based Incentive Payment System using Qualified Clinical Data Registries. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer asking to preserve viability of physician practices by including certain provisions in any upcoming COVID-19 legislation. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging Congress to include language from H.R. 7059, the Coronavirus Provider Protection Act that would provide liability protections for physicians in the next COVID-19 legislative package. Coalition letter addressed to Rep. Phil Roe, M.D. and Lou Correa thanking them for introduction and expressing support for H.R. 7059, the Coronavirus Provider Protection Act. Coalition letter addressed to the Administrator of the Center for Medicare & Medicaid Services stating opposition to expanding the scope of services NPPs furnish in IRFs, and urging CMS to uphold the role of the rehabilitation physician in delivering and overseeing care for patients in IRF settings. Coalition letter addressed to Representatives Diana DeGette and Fred Upton requesting to include in any upcoming COVID-19 legislation language guaranteeing clinical data registries access to Medicare claims data for quality improvement, patient safety, and research purposes, all of which are necessary to build an evidence-based shift to value-based care. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602. H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions. S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions. S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions. H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions. H.R. 663, the Truth in Healthcare Marketing Act of 2020, all provisions. H.R. 7059, the "Coronavirus Provider Protection Act," all provisions. Issues pertaining to the COVID-19 pandemic, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to scope of practice legislation; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to healthcare liability reform, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Secretary of the U.S. Department of Health and Human Services urging HHS to provide one month of revenue to each physician, nurse practitioner, and physician assistant enrolled in Medicare or Medicaid to account for financial losses and non-reimbursable expenses. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions such as student loan relief, medical liability protections, supply chain support and others in a future COVID-19 legislative package. Coalition letter addressed to Quality Measurement and Value-Based Incentives Group urging CMS to encourage clinicians and groups to report under the Merit-Based Incentive Payment System using Qualified Clinical Data Registries. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer asking to preserve viability of physician practices by including certain provisions in any upcoming COVID-19 legislation. Coalition letter addressed to the Administrator of the Center for Medicare & Medicaid Services stating opposition to expanding the scope of services NPPs furnish in IRFs, and urging CMS to uphold the role of the rehabilitation physician in delivering and overseeing care for patients in IRF settings. Coalition letter addressed to Representatives Diana DeGette and Fred Upton requesting to include in any upcoming COVID-19 legislation language guaranteeing clinical data registries access to Medicare claims data for quality improvement, patient safety, and research purposes, all of which are necessary to build an evidence-based shift to value-based care. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602. H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions. S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions. S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions. H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to the COVID-19 pandemic, in general.

Agencies Lobbied

Type of Issue

1st Quarter, 2020

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2020. Original Filing: 301177701.xml

Lobbying Issues

Coalition letter addressed to the Chairman and Ranking Members of the House Energy and Commerce and Ways and Means Committees urging opposition to H.R. 4056, the Medicare Audiologist Access and Services Act." Coalition letter addressed to the Majority and Minority Leaders as well as the Chairman and Ranking Member of the Senate Finance Committee regarding opposition to S. 2446, the Medicare Audiologist Access and Services Act. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions that would protect physicians on the frontline, support existing resources, ensure access to necessary care and protect physician practices in COVID-19 relief legislation. Coalition letter addressed to Senators Michael Bennet and John Barrasso expressing support for S. 3449 the Immediate Relief for Rural Facilities and Providers Act" and urge inclusion in a COVID-19 relief package. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians through tax relief, no-interest loans, direct payments, payment for virtual visits including phone calls, and other measures. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602. S.1350, Good Samaritan Health Professionals Act, A bill to amend the Public Health Service Act to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster, all provisions. H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions. S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions. S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions. H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to Graduate Medical Education; in general. Issues pertaining to the COVID-19 pandemic, in general. Issues pertaining to scope of practice legislation; in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Federal "Truth in Advertising" Legislation; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter to the Secretary of the U.S. Department of Health and Human Services regarding CMS MIPS quality measure selection and removal policy as finalized in the 2020 Physician Fee Schedule/Quality Payment Program (QPP) Final Rule. The letter recommended policies in order to strengthen and make the MIPS program more meaningful. Coalition letter to the Administrator of the Centers for Medicare & Medicaid Services regarding CMS' request for information on scope of practice of health care professionals. Letter to the Administrator of the Centers for Medicare & Medicaid Services regarding the President's Executive Order #13890 on protecting and improving Medicare for our nation's seniors on supervision requirements for physician assistants. Coalition letter addressed to the Chairman and Ranking Members of the House Energy and Commerce and Ways and Means Committees urging opposition to H.R. 4056, the Medicare Audiologist Access and Services Act. Coalition letter to addressed to the Minority and Minority Leaders as well as the Chairman and Ranking Member of the Senate Finance Committee regarding opposition to S. 2446, the Medicare Audiologist Access and Services Act. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions that would protect physicians on the frontline, support existing resources, ensure access to necessary care and protect physician practices in COVID-19 relief legislation. Coalition letter addressed to Senators Michael Bennet and John Barrasso expressing support for "the Immediate Relief for Rural Facilities and Providers Act" and urge inclusion in a COVID-19 relief package. Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by through tax relief, no-interest loans, direct payments, payment for virtual visits including phone calls, and other measures. H.R.3107, the Improving Seniors Timely Access to Care Act, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes, all provisions. H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602. H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions. S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions. S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions. H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions. Issues pertaining to the COVID-19 pandemic, in general. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to scope of practice legislation; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2019

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 16, 2020. Original Filing: 301107775.xml

Lobbying Issues

Coalition letter addressed to the Speaker and Republican Leader of the House of Representatives regarding the need for a legislative solution to protect patients from surprise medical bills without the use of rate-setting provisions seen in current bills like H.R. 2328 that would further shift marketplace leverage to health insurers at the expense of providers. Coalition letter addressed to the Senate Majority and Minority Leader regarding the need for a legislative solution to protect patients from surprise medical bills without the use of rate-setting provisions seen in current bills like S. 1895 that would further shift marketplace leverage to health insurers at the expense of providers. Coalition letter addressed to Secretary Azar at HHS regarding concerns with a vague provision in an October 3, 2019 Executive Order entitled, "Protecting and Improving Medicare for our Nation's Seniors", that potentially could require HHS to eliminate or weaken current Medicare supervision requirements of nonphysician professionals, a critical safeguard for patient safety. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to scope of practice legislation; in general, including H.R. 3, H.R. 4056, and S. 2446. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Graduate Medical Education; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Speaker and Republican Leader of the House of Representatives regarding the need for a legislative solution to protect patients from surprise medical bills without the use of rate-setting provisions seen in current bills like H.R. 2328 that would further shift marketplace leverage to health insurers at the expense of providers. Coalition letter addressed to the Senate Majority and Minority Leader regarding the need for a legislative solution to protect patients from surprise medical bills without the use of rate-setting provisions seen in current bills like S. 1895 that would further shift marketplace leverage to health insurers at the expense of providers. Coalition letter addressed to Secretary Azar at HHS regarding concerns with a vague provision in an October 3, 2019 Executive Order entitled, "Protecting and Improving Medicare for our Nation's Seniors", that potentially could require HHS to eliminate or weaken current Medicare supervision requirements of nonphysician professionals, a critical safeguard for patient safety. Coalition letter addressed to CMS expressing concerns about requirements for pre-submission audits by QCDRs and QRs of the Improvement Activities (IA) and Promoting Interoperability (PI) categories of MIPS. Coalition letter addressed to CMS expressing concerns about QCDRs and measure testing requirements. Issues related to hearing healthcare; in general. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues pertaining to scope of practice legislation; in general, including H.R. 3, H.R. 4056, and S. 2446. Issues pertaining to surprise out of network bills, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2019

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 18, 2019. Original Filing: 301070547.xml

Lobbying Issues

Coalition letter addressed to the Chairman and Ranking Member of the U.S. Committee on Energy and Commerce regarding the need for an independent dispute resolution (IDR) process in any surprise billing legislative solution. Coalition letter addressed to House Energy and Commerce Committee, House Ways and Means Committee, House Education and Labor Committee, and Senate Health, Education, Labor, and Pensions Committee regarding the surprise billing issue and the need for an independent dispute resolution process. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services regarding agency activities on prior authorization reform, as part of the Patients Over Paperwork initiative. Issues pertaining to health information technology and electronic health records (EHR); in general. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues related to hearing healthcare; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to scope of practice; in general. Issues pertaining to Graduate Medical Education; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Chairman and Ranking Member of the U.S. Committee on Energy and Commerce regarding the need for an independent dispute resolution (IDR) process in any surprise billing legislative solution. Coalition letter addressed to House Energy and Commerce Committee, House Ways and Means Committee, House Education and Labor Committee, and Senate Health, Education, Labor, and Pensions Committee regarding the surprise billing issue and the need for an independent dispute resolution process. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services expressing opposition to CMS' proposal to not incorporate the RUC-recommended E/M values into CPT codes with global periods. Coalition letter addressed to the Administrator of the Centers for Medicare & Medicaid Services regarding agency activities on prior authorization reform, as part of the Patients Over Paperwork initiative. Issues pertaining to health information technology and electronic health records; in general. Issues pertaining to surprise out-of-network bills; in general. Issues related to prior authorization, in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues related to hearing healthcare; in general. Issues pertaining to scope of practice; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2019

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 22, 2019. Original Filing: 301056708.xml

Lobbying Issues

Issues pertaining to health information technology and electronic health records (EHR); in general. Coalition comment letter to the Office of the National Coordinator (ONC)for Health Information Technology at the Dept. of Health and Human Services (HHS) regarding the draft Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHR. Coalition letter to Administrator of the Maternal and Child Health Bureau within the Health Resources and Services Administration (HRSA)requesting a meeting to discuss issues around the Early Hearing and Detection Intervention (EHDI) program. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues related to hearing healthcare; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to scope of practice; in general. H.Res.147, Expressing Support for the Designation of March 3, 2019, as World Hearing Day. Issues pertaining to Graduate Medical Education; in general. Coalition letter addressed to the House calling on policymakers to address the growing physician shortage by passing H.R. 1763, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Senate calling on policymakers to address the growing physician shortage by passing S.348, the Resident Physician Shortage Reduction Act of 2019. Coalition letter thanking Dr. Warren, Associate Administrator of Bureau of Maternal and Child Health for meeting with Audiology and Hearing groups on March 22 regarding support for families in need of assistive hearing technologies and communication modalities. Coalition Letter addressed to the National Coordinator for Health Information Technology regarding the ONC's proposed rule to implement certain provisions of the 21st Century Cures Act. Coalition Letter addressed to the Administrator of Centers for Medicare & Medicaid Services regarding the CMS's proposed rule to improve interoperability and access to health care data.

Agencies Lobbied

Type of Issue

Lobbying Issues

Issues pertaining to health information technology and electronic health records; in general. Coalition letter to CMS Administrator urging CMS to provide guidance to Medicare Advantage plans on prior authorization through its 2020 Call Letter. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out-of-network bills; in general. Coalition letter addressed to the Director of the Office for Civil Rights (OCR) within the Dept. of Health and Human Services (HHS) regarding a RFIon "Modifying HIPPAA Rules to Improve Coordinated Care." Issues related to prior authorization, in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues related to hearing healthcare; in general. Issues pertaining to scope of practice; in general. Coalition letter addressed to the House calling on policymakers to address the growing physician shortage by passing H.R. 1763, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Senate calling on policymakers to address the growing physician shortage by passing S.348, the Resident Physician Shortage Reduction Act of 2019. Coalition letter addressed to the Speaker of the House and Minority Leader urging Congress to make further refinements to improve MACRA, including replacing the 2020-2025 physician payment update freeze with positive payment adjustments for physicians. Coalition letter addressed to the Senate Majority Leader and Minority Leader urging Congress to make further refinements to improve MACRA, including replacing the 2020-2025 physician payment update freeze with positive payment adjustments for physicians.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Chair and Ranking Member of the U.S. House of Representatives Appropriations Subcommittee on Labor, Health,and Human Services, Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies. Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman of the House Energy and Commerce Committee expressing support for H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2019

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 22, 2019. Original Filing: 301034082.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies. Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Coalition letter addressed to the Chair and Ranking Member of the U.S. House of Representatives Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2019

Amendment

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY amended a lobbying report for in-house lobbying in Q12019 on April 22, 2019 Original Filing: 301035976.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2018

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 17, 2019. Original Filing: 301006981.xml

Lobbying Issues

Federal "Truth in Advertising" legislation; in general. H.R. 3928, the "Truth in Healthcare Marketing Act," all provisions. Issues pertaining to scope of practice; in general. Health care reform efforts; in general. Repeal of the Affordable Care Act, in general. Letter to the Food and Drug Administration regarding the forthcoming regulations relating to the over-the-counter sale of hearing aids. Letter to the Food and Drug Administration regarding National Shortages of Lidocaine with Epinephrine, Lidocaine, and Other Local Anesthetics. Coalition Letter to the Department of Health and Human Services Office of the Inspector General regarding information blocking by Electronic Health Record Vendors. Letter to Congress regarding H.R. 5247/S. 204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, all provisions. H.Res.740, Expressing Support for the Designation of March 3, 2018, as World Hearing Day. H.R. 6, the SUPPORT for Patients and Communities Act; Section 303. S. 2852, the Pandemic All Hazards Preparedness and Advancing Innovation Act of 2018; provisions related to malpractice/tort reform and H.R. 1876. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. H.R. 1120, the "Alice Cogswell and Anne Sullivan Macy Act," all provisions. Coalition letter to the National Coordinator for Health Information Technology at HHS regarding HHS-ONC-2018-022 - Request for Information Regarding the 21st Century Cures Act Electronic Health Reporting Program.

Agencies Lobbied

Type of Issue

Lobbying Issues

H.R. 2276/S. 2575, the "Audiology Patient Choice Act," all provisions. Medicare physician payment reform and implementation of the Medicare and CHIP Reauthorization Act of 2015, in general. Medicare physician payment reform and implementation of the Medicare and CHIP Reauthorization Act of 2015 related to the cost domain of the Merit-based Incentive Payment System. H.R. 1156, the "Patient Access to Higher Quality Health Care Act of 2017," all provisions. H.R. 849/S. 260, the "Protecting Seniors' Access to Medicare Act of 2017," all provisions. Comments outlining concern with the November 2017 Medicare Payment Advisory Commission (MedPAC) discussion titled, "Rebalancing the physician fee schedule towards primary care services." Issues pertaining to scope of practice, in general. Comments urging the Centers for Medicare and Medicaid Services (CMS) to reduce the 2018 Merit-based Incentive Payment System (MIPS) reporting period from a calendar year to a minimum of 90 consecutive days. Comments on the Medicare Hospital IPPS FY 2019 Proposed Rule communicating concerns about the agencys plans to remove the Public Health and Clinical Data Exchange objective by 2022. Comments urging leaders of the U.S. Senate Committee on Finance not to co-sponsor and oppose any efforts to advance the "Audiology Patient Choice Act" (S. 2575). Comments to the Centers for Medicare and Medicaid Services (CMS) regarding Medicare's designation of CPT Code 31241 Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery. Coalition letter to leaders of the U.S. House Committees on Ways & Means and Energy & Commerce regarding the Medicare Appropriate Use Criteria (AUC) Program for Advanced Diagnostic Imaging. Coalition letter to leaders of the U.S. Senate Committee on Finance regarding the Medicare Appropriate Use Criteria (AUC) Program for Advanced Diagnostic Imaging. Coalition letter to U.S. House Committees on Ways & Means and Energy and Commerce and U.S. Senate Committee on Finance regarding payment cuts for clinical lab tests in the Medicare program. Coalition letter to the CMS Administrator urging HHS to allow eligible clinicians utilizing a certified electronic health record to participate in a clinician-led qualified clinical data registry to qualify them as fully achieving all points from the MIPS program. Coalition letter to the CMS Administrator regarding the Evaluation and Management coding and payment recommendations included in the CY19 Medicare Physician Fee Schedule Proposed Rule. Coalition letter to U.S. House of Representatives requesting support of a letter to HHS Secretary Alex Azar regarding data information blocking guidelines as related to Qualified Clinical Data Registries. Comments on the CY19 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule communicating support for proposed changes to reduce site of service disparities, as well as removal of CPT 31241 (Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery) from the Inpatient Only List. Comments on the CY19 Medicare Physician Fee Schedule Proposed Rule regarding the proposed changes to documentation requirements, coding and payment for Evaluation and Management (E/M) services, application of the MPPR to E/M services, and the pricing and composition of balloon sinus surgery kits. Coalition Letter to leaders of the U.S. Senate Committee on Finance and U.S. House Committees on Ways and Means and Energy and Commerce regarding cuts to clinical laboratory services implemented by the Protecting Access to Medicare Act (PAMA) of 2014. Coalition letter to U.S. Senate Finance Committee and U.S. House Committees on Ways and Means and Energy and Commerce expressing concerns with CMS proposal to require Qualified Clinical Data Registry (QCDR) measure owners to enter into licensing agreements with CMS that would permit any other approved QCDR to submit data on the licensed measure for purposes of MIPS reporting. Comments on the CY19 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule regarding changes to reduce site of service disparities, as well as removal of CPT 31241 (Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery) from the Inpatient Only List. Comments on the CY 2019 Physician Fee Schedule Final Rule regarding the changes to documentation requirements, coding and payment for Evaluation and Management (E/M) services, application of the MPPR to E/M services, and the pricing and composition of balloon sinus surgery kits. Coalition letter to CMS expressing several concerns with Qualified Clinical Data Registries and MIPS. Coalition letter to CMS in response to an RFI regarding reporting requirements under the Open Payments Program for educational materials.

Agencies Lobbied

Type of Issue

Lobbying Issues

H.R. 1892, the "Bipartisan Budget Act of 2018," provisions related to healthcare. Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Coalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the "Early Hearing Detection and Intervention (EHDI) Act of 2017." Coalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars. FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders. Coalition letter to leaders of the U.S. House Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks. Coalition letter to leaders of the U.S. Senate Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks.

Agencies Lobbied

Type of Issue

Lobbying Issues

H.R. 1215, the "Protecting Access to Care Act," all provisions. H.R. 1704, the "Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act," all provisions. H.R. 1876, the "Good Samaritan Health Professionals Act of 2017," all provisions. Comments urging floor action in regards to the Good Samaritan Health Professionals Act of 2018 (H.R. 1876). Coalition letter to the Speaker of the House in support of the Good Samaritan Health Professionals Act of 2018 (H.R. 1876). Coalition letter to leaders of the U.S. House Committee on Energy & Commerce requesting inclusion of H.R. 1876 in the Pandemic and All Hazards Preparedness Re-authorization Act of 2018 (S. 2852). S. 2852, the Pandemic All Hazards Preparedness and Advancing Innovation Act of 2018; provisions related to malpractice/tort reform and H.R. 1876.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Opposition to H.R. 564 and any appropriations riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Support for any legislation and/or regulation requiring all non-grandfathered private health insurance plans to cover preventative services given an "A" or "B" rating by the U.S. Preventative Services Taskforce (USPSTF), especially provisions relating to comprehensive benefits for tobacco cessation services. Opposition to H.R. 1136, the "FDA Deeming Authority Clarification Act of 2017," all provisions. Comments supporting the Food and Drug Administration's initiative to move toward a product standard to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels. Coalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to leaders of the U.S. House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, urging allocation of funds for the Centers for Disease Control and Prevention's Office on Smoking and Health. Coalition letter to leaders of the U.S. Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies urging allocation of funds for the Centers for Disease Control and Prevention's Office on Smoking and Health. Coalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars. FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders. Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco provision in the U.S-Japan Free Trade Agreement with Japan, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2018

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 18, 2018. Original Filing: 300989403.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2018

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2018. Original Filing: 300973479.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2018

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2018. Original Filing: 300954722.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2017

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 19, 2018. Original Filing: 300927979.xml

Lobbying Issues

Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products. For FY18, opposition to the inclusion of either of two policy riders originally included in the House Appropriations Committees Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill that would weaken FDAs authority to oversee tobacco products. Opposition to the House Appropriations Committees proposed 25% cut to the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH).

Agencies Lobbied

Type of Issue

Lobbying Issues

Comments to HHS' Office for Human Research Protections on finalization of the rule on the Federal Policy for the Protection for Human Subjects; including: single IRB review mandate, revisions to the Common Rules informed consent requirements, and numerous other modifications. Comments to the Food and Drug Administration (FDA) Re: Docket Number FDA-2016-D-3466; Immediately in Effect Guidance Document: Conditions for Sale for Air Conduction Hearing Aids. Federal "Truth-in-Advertising" legislation; in general. Issues pertaining to scope of practice; in general. Repeal of the Affordable Care Act; in general. Comments to the Food and Drug Administration re: Docket No. FDA-2016-D-2268 for Insanitary Conditions at Compounding Facilities Comments to the Food and Drug Administration re: Docket 2014-D-1525-0358; Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application; Revised Draft Guidance For Industry. H.R.1652/S. 670, the "Over-the-Counter Hearing Aid Act of 2017," all provisions. H.R. 2430, the "FDA Reauthorization Act of 2017," provisions relating to the over-the-counter sale of hearing aids. Comments to the Federal Trade Commission Re: Notice of Workshop and Requesting Public Comments; Hearing Health and Technology - Workshop, Project No. P171200. Concerns regarding the potential impact of a revised United States Pharmacopeia (USP) Chapter 797 on physician practices and patient access to critical sterile drug products. H.R.1628 - American Health Care Act of 2017; in general. The "Better Care Reconciliation Act"; in general. Support for the nomination and confirmation of Jerome Adams, MD, to serve as the United States Surgeon General. H.R.3928, the "Truth in Healthcare Marketing Act of 2017;" all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare physician payment reform and implementation of the Medicare Access and CHIP Reauthorization Act of 2015, in general. Comments to CMS requesting a deferment from implementing 2015 Edition certified electronic health record technology (CEHRT) until such technology is widely available, and, in no event, sooner than January 2019. Comments re: Advance Notice of Methodological Changes for Calendar Year (CY) 2018 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2018 Call Letter (Call Letter). H.R.1156, the "Patient Access to Higher Quality Health Care Act of 2017," all provisions. H.R.849/S. 260, the "Protecting Seniors' Access to Medicare Act of 2017," all provisions. S.251, the "Protecting Medicare from Executive Action Act of 2017," all provisions. Comments requesting relief from 2018 penalties to be imposed on physicians pursuant to the Value Modifier (VM), Meaningful Use (MU) and Physician Quality Reporting System (PQRS) programs. Comments Final Rule re: Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2017; Medicare Advantage Bid Pricing Data Release; Medicare Advantage and Part D Medical Loss Ratio Data Release; Medicare Advantage Provider Network Requirements; Expansion of Medicare Diabetes Prevention Program Model; Medicare Shared Savings Program Requirements. Topics included: 1.) Practice Expense; 2.) Potentially Misvalued Services under the Fee Schedule; 3.) Improving Valuation of the Global Surgical Package; 4.) Reducing Administrative Burden and Improving Payment Accuracy for Chronic Care Management Services; 5.) Valuation of Specific Codes; 6.) Appropriate Use Criteria for Advanced Imaging Screening; 7.) Accountable Care Organizations (ACO) Participants Who Report Physician Quality Reporting System (PQRS) Quality Measures Separately; and 8.) Value-Based Payment Modifier and Physician Feedback Program. Issues pertaining to scope of practice; in general. Comments re: Collecting Data on Resources Used in Furnishing Global Services per the calendar year (CY) 2017 Medicare Physician Fee Schedule (MPFS) Final Rule. Comments re: the Centers for Medicare & Medicaid Services (CMS) planned enactment of the Social Security Number Removal Initiative (SSNRI). Comments re: relief from the administrative burdens and significant financial penalties slated to be imposed on physicians in 2018 as part of the Medicare physician fee schedule. H.R. 2276, the "Audiology Patient Choice Act," all provisions. Comments re: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2018 Rate. Support for allowing eligible clinicians utilizing an electronic health record to participate in a qualified clinical data registry to qualify them as fully achieving all points for the Advancing Care Information category of the Quality Payment Programs Merit Based Incentive Payment System. Concerns regarding the difficulty Qualified Clinical Data Registries (QCDRs) have experienced with the QCDR measure review and self-nomination process under the Merit-based Incentive Payment System (MIPS), which was established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Support for efforts to improve the transparency regarding Medicare Advantage (MA) plan prior authorization requirements. Support for the implementation of the Unique Device Identifier (UDI) through electronic health records (EHRs) and clinical registries in order to achieve the congressional intent of promoting patient safety by ensuring all patients and their healthcare providers as well as public health officials and researchers have accurate and complete information on medical devices. Comments re: "Medicare Program; CY 2018 Updates to the Quality Payment Program (QPP)," published in the Federal Register on June 30, 2017. Topics included: changes in reporting requirements, classification of measures, ACI performance category credit, APMs, and the use of QCDRs and certified EHR technology (CEHRT) for reporting measures under the Quality performance category of the Merit-Based Incentive Payment System (MIPS). Comments on the "Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2018; Medicare Shared Savings Program Requirements; and Medicare Diabetes Prevention Program," published in the Federal Register on July 21, 2017. Topics included: 1.) Practice Expense; 2.) Crosswalking PLI for Non-Physicians; 3.) Potentially Misvalued Services under the Fee Schedule; 4.) Valuation of Specific Codes; 5.) Appropriate Use Criteria for Advanced Imaging Screening; 6.) Physician Quality Reporting System Criteria for Satisfactory Reporting for Individual EPs and Group Practices for the 2018 PQRS Payment Adjustment; 7.) Clinical Quality Measurement for Eligible Professionals Participating in the Electronic Health Records (EHR) Incentive Program for 2016; 8.) Value-Based Payment Modifier and Physician Feedback Program; and 9.) MACRA Patient Relationship Categories and Codes. Comments re: FY 2018 Medicare Hospital Inpatient Prospective Payment System and Long-Term Acute Care Hospital Prospective Payment System Final Rule, published in the Federal Register as a proposed rule on August 2, 2017. Comments re: the CY 2018 Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs, published in the Federal Register as a proposed rule. Topics included: 1.) CY 2018 Comprehensive Ambulatory Payment Classifications (C-APCs); 2.) Imaging APCs; and 3.) Changes for Computed Tomography (CT) under the Protecting Access to Medicare Act of 2014 (PAMA); and 4.) New Bundled Sinus Codes Payment in the Ambulatory Surgical Center (ASC). Concerns with new methodology for updating malpractice (MP) relative value units (RVUs) as discussed in the calendar year (CY) 2018 Medicare Physician Fee Schedule (PFS) proposed rule. Comments to the House Ways & Means Committee in response to its "Medicare Red Tape Relief Project." Topics included: scope of practice, the Quality Payment Program (QPP) and clinical data registries. Support for statutory changes to MACRA that will allow CMS to provide an additional three years of flexibility as necessary program elements are put in place. Comments outlining concerns re: the commercial misuse of quality measures developed for the Merit-based Incentive Payment System (MIPS), which was established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), and requests that CMS issue sub-regulatory guidance about the ownership and licensing of MIPS measures as it has issued for QCDR measures. Opposition to the inclusion of Medicare cuts (in general) in the tax bill, an end of year spending package, or other legislation, that could threaten patient access to quality care. Comments via the Physician Clinical Registry Coalition re: CMS-5522-FC - Medicare Programs: CY 2018 Updates to the Quality Payment Program. Comments to CMS re: the Innovation Center New Direction Request for Information, posted on the CMS Innovation Center website on September 20, 2017. The AAO-HNS urged CMMI to adopt several strategies to design and implement new APMs consistent with the guiding principles, including support for physician-driven approaches to APM models. Comments to CMS re: Medicare; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year. Comments to MedPAC highlighting the significant benefits of clinical data registries and the role they should play in achieving the goals of the Quality Payment Program (QPP). Opposition to current methodologies used to survey and assess values associated with Global Surgical Services.

Agencies Lobbied

Type of Issue

Lobbying Issues

Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Support for legislation and/or regulation requiring all non-grandfathered private health insurance plans to cover preventative services given an "A" or "B" rating by the U.S. Preventative Services Task Force (USPSTF), especially provisions relating to comprehensive benefits for tobacco cessation services. Opposition to H.R. 1136, the "FDA Deeming Authority Clarification Act of 2017," all provisions. Comments to the Department of Housing and Urban Development re: Reducing Regulatory Burden; Enforcing the Regulatory Reform Agenda Under Executive Order 13777; Docket No. FR-6030-N-01. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Comments re: Docket No. USTR-2017-0006; provisions relating to public health measures to protect citizens from the death and disease caused by tobacco products. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Comments in support of Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products, Docket No. FDA-2016-N-2527. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products. For FY18, opposition to the inclusion of either of two policy riders originally included in the House Appropriations Committees Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill that would weaken FDAs authority to oversee tobacco products. Opposition to the House Appropriations Committees proposed 25% cut to the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH).

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2017

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 19, 2017. Original Filing: 300910191.xml

Lobbying Issues

Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Support for legislation and/or regulation requiring all non-grandfathered private health insurance plans to cover preventative services given an "A" or "B" rating by the U.S. Preventative Services Task Force (USPSTF), especially provisions relating to comprehensive benefits for tobacco cessation services. Opposition to H.R. 1136, the "FDA Deeming Authority Clarification Act of 2017," all provisions. Comments to the Department of Housing and Urban Development re: Reducing Regulatory Burden; Enforcing the Regulatory Reform Agenda Under Executive Order 13777; Docket No. FR-6030-N-01. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Comments re: Docket No. USTR-2017-0006; provisions relating to public health measures to protect citizens from the death and disease caused by tobacco products. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Comments in support of Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products, Docket No. FDA-2016-N-2527. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2017

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2017. Original Filing: 300897341.xml

Lobbying Issues

Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA).

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2017

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2017. Original Filing: 300875691.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2016

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2017. Original Filing: 300852307.xml

Lobbying Issues

H.R. 1344/S. 2424, "the Early Hearing Detection and Intervention Act of 2015," all provisions. Reauthorization of NASPER, the federal program providing support for state Prescription Drug Monitoring Programs. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY17. Funding for Graduate Medical Education, in general. Funding for NIH and medical research, in general. Funding to the Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Funding for the Pediatric Device Consortia for 2017. Funding for Human Temporal Bone Laboratories in the US. Opposition to policy riders in the House/Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for Fiscal Year 2017 that would weaken FDA's authority to regulate tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Comments to the Institute of Medicine's Committee on Accessible and Affordable Hearing Health Care for Adults regarding the delivery of hearing healthcare services in the United States. Encourage USP to maintain current rules applicable to allergen extracts with sterile compounding. H.R. 1741, the "Truth in Healthcare Marketing Act of 2015," all provisions. H.R. 1859/S. 2782, the "Ensuring Childrens Access to Specialty Care Act," all provisions. S. 2978, the Protect Continuing Physician Education and Patient Care Act," all provisions. Support for the inclusion of language in S.2511, the "Improving Health Information Technology Act," aimed at eliminating information blocking and enhancing data exchange between electronic health record technology and clinical data registries. Comments re:Docket No. FDA-2015-N-4602 for Streamlining Regulations for Good Manufacturing Practices for Hearing Aids; Public Workshop; Request for Comments. Support for provisions in the "21st Century Cures" bill relating to the exchange of clinical outcomes data between electronic health record (EHR) technologies and clinician-led clinical data registries, including provisions to promote and facilitate interoperability of clinical data and to prevent EHR vendors from blocking the transmission of such data to third parties, including clinician-led clinical data registries. Comments re: Docket No. FDA-2016-D-2268 for Insanitary Conditions at Compounding Facilities.

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare physician payment reform, in general. Implementation of MACRA, the Medicare Access and CHIP Reauthorization Act of 2015. Audiology-related legislation, in general. H.R. 1116, the "Medicare Audiology Services Enhancement Act of 2015," all provisions. Flexibility of the Meaningful Use Program, in general. Support for the appointment of a surgeon to the Medicare Payment Advisory Commission (MedPAC). H.R. 2519, the "Audiology Patient Choice Act of 2015," all provisions. Regulatory approaches that allow Qualified Clinical Data Registries to meet quality requirements under MACRA and Meaningful Use and addressing unfair data blocking policies. Communications assessing interoperability for the Medicare Access and CHIP Reauthorization Act (MACRA), which directs the Secretary of the U.S. Department of Health and Human Services (HHS) to establish metrics to determine if and to what extent interoperability has been achieved. Support for the inclusion of language in S.2511, the "Improving Health Information Technology Act," aimed at eliminating information blocking and enhancing data exchange between electronic health record technology and clinical data registries. Comments re: Medicare Program; Merit-based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models. Opposition to the provision in the Centers for Medicare and Medicaid Services (CMS) Physician Fee Schedule (PFS) proposed rule for calendar year (CY) 2017 to collect all data for all 10- and 90-day global services from all practitioners who perform these services, rather than from a representative sample of practitioners, which was required by The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Comments in support of the Centers for Medicare and Medicaid Services (CMS) restoring the Refinement Panel to serve as the relative value appeals process that was appropriately in place prior to 2011. Comments re: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2017. Comments re: CY 2017 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1656-P. Comments expressing concern about the quasi-qualified entity provisions of the final rule, Medicare Program: Expanding Uses of Medicare Data by Qualified Entities." Comments/concerns regarding efforts to require Qualified Clinical Data Registries (QCDRs) to consolidate one or more of their proposed non-PQRS quality measures with (a) existing, traditional PQRS quality measures, (b) other non-PQRS measures proposed by other QCDRs, or (c) non-PQRS measures proposed by the QCDR. Comments re: CMS-5517-FC - Medicare Program: Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models for use of QCDRs and certified electronic health record technology (CEHRT) for reporting measures under the Quality performance category. Comments re: "Medicare Program; Merit-based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models," published in the Federal Register on November 4, 2016. Comments re: CY 2017 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1656-FC and IFC, published in the Federal Register as a final notice on November 14, 2016, addressing: 1.) Additional Comprehensive Ambulatory Payment Classifications (C-APCs); 2.) Procedures Assigned to New Technology APC Groups for CY 2017; and 3.) Changes for Computed Tomography (CT) under the Protecting Access to Medicare Act for 2014 (PAMA). Repeal of the Independent Payment Advisory Board (IPAB); in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Food and Drug Administration oversight of tobacco products, in general. Tobacco control provisions of the Trans-Pacific Partnership (TPP) trade agreement, in general. Pre-market review provisions of the Tobacco Control Act, in general. Funding to the Centers for Disease Control and Prevention (CDC) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Implementation of a smoke-free policy in all public housing. H.R. 3242/S. 142, the "Child Nicotine Poisoning Prevention Act of 2015," all provisions. Support for finalization of deeming regulations re: all tobacco products. Opposition to policy riders in the House/Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for Fiscal Year 2017 that would weaken FDA's authority to regulate tobacco products. Opposition to the $110 million funding cut in the House FY 2017 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH). Comments to the FDA re: requirement that all non-grandfathered private health insurance plans cover preventive services given an A or B rating by the U.S. Preventive Services Task Force (USPSTF), including the availability of comprehensive benefits for tobacco cessation services.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2016

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2016. Original Filing: 300834593.xml

Lobbying Issues

H.R. 1344/S. 2424, "the Early Hearing Detection and Intervention Act of 2015," all provisions. Reauthorization of NASPER, the federal program providing support for state Prescription Drug Monitoring Programs. Agency for Healthcare Research and Quality (AHRQ) funding request for 2017. Funding for Graduate Medical Education, in general. Funding for NIH and medical research, in general. Funding to the Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Funding for the Pediatric Device Consortia for 2017. Funding for Human Temporal Bone Laboratories in the US. Opposition to policy riders in the House/Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for Fiscal Year 2017 that would weaken FDA's authority to regulate tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2016

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2016. Original Filing: 300819587.xml

Lobbying Issues

H.R. 1344/S. 2424, "the Early Hearing Detection and Intervention Act of 2015," all provisions. Reauthorization of NASPER, the federal program providing support for state Prescription Drug Monitoring Programs. Agency for Healthcare Research and Quality (AHRQ) funding request for 2017. Funding for Graduate Medical Education, in general. Funding for NIH and medical research, in general. Funding to the Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Funding for the Pediatric Device Consortia for 2017. Funding for Human Temporal Bone Laboratories in the US. Opposition to policy riders in the House/Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for Fiscal Year 2017 that would weaken FDA's authority to regulate tobacco products.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2016

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2016. Original Filing: 300801725.xml

Lobbying Issues

H.R. 1344/S. 2424, the Early Hearing Detection and Intervention Act of 2015, all provisions. Reauthorization of NASPER, the federal program providing support for state Prescription Drug Monitoring Programs. Agency for Healthcare Research and Quality (AHRQ) funding request for 2017. Funding for Graduate Medical Education, in general. Funding for NIH and medical research, in general. Funding to the Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Funding for the Pediatric Device Consortia for 2017. Funding for Human Temporal Bone Laboratories in the US.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Food and Drug Administration oversight of tobacco products, in general. Tobacco control provisions of the Trans-Pacific Partnership (TPP) trade agreement, in general. Premarket review provisions of the Tobacco Control Act, in general. Funding to the Centers for Disease Control and Prevention (CDC) for tobacco cessation intervention and preventive services. Approval of the authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products and to oppose any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Implementation of a smoke-free policy in all public housing. H.R. 3242/S. 142, the Child Nicotine Poisoning Prevention Act of 2015, all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2015

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 14, 2016. Original Filing: 300772164.xml

Lobbying Issues

Medicare physician payment reform; in general. H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; all provisions. H.R. 1470, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015; all provisions. Audiology-related legislation; in general. H.R. 1116, the Medicare Audiology Services Enhancement Act of 2015. Repeal of the Independent Payment Advisory Board (IPAB); in general. H.R. 1190/S.141, the Protecting Seniors' Access to Medicare Act of 2015; all provisions. Certification of electronic health records (EHRs); in general. Medicare Advantage "Network Adequacy"; in general. Opposition to proposed policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global payment period codes to 0-day global period codes in 2017, and 2018, respectively. Implementation plans for moving to ICD-10, a code set named under the Health Insurance Portability and Accountability Act (HIPAA). Support for the appointment of a surgeon to the Medicare Payment Advisory Commission (MedPAC). Implementation of Section 218 (b) of Public Law 113-93, entitled the Protecting Access to Medicare Act (PAMA), relating to the possible consideration of Radiology Benefit Management (RBM) companies as potential sources for the establishment of applicable appropriate use criteria, as well as any use of RBMs for the enforcement of the prior authorization section for ordering professionals who are outliers. Comments re: funding of quality measures authorized under section 102 of the recently enacted Medicare Access and CHIP Reauthorization Act of 2015, or MACRA, Public Law 114-10. H.R. 2519, Audiology Patient Choice Act of 2015; all provisions. Support for the appointment of a surgeon to the Physician-Focused Payment Model Technical Advisory Committee (PTAC) created under the Medicare Access and CHIP Reauthorization Act (MACRA). Support for H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability Act or Flex IT 2 Act"; all provisions. Communications urging the Administration to "pause" implementation of Stage 3 Meaningful Use (MU) and reevaluate the program in light of pivotal changes to Medicare, including passage of the Medicare Access and Chip Reauthorization Act (MACRA). Communication to the Centers for Medicaid and Medicare Services (CMS) regarding the "CY 2016 Hospital Outpatient PPS Policy changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1633-P, published in the Federal Register as a proposed notice on July 8, 2015. Comments address 1.) Changes for Computed Tomography (CT) under the Protecting Access to Medicare Act of 2014 (PAMA); 2.) Proposed New Technology APCs - Orthopedic Procedures. Communication to the Centers for Medicaid and Medicare Services (CMS) regarding the "Medicare Program; Revisions for Part B for CY 2016" published in the Federal Register as a proposed notice on July 15, 2015. Comments address 1.) 2016 Conversion Factor (CF); 2.) Practice Expense Issues; 3.) Potentially Misvalued Services Under the Fee Schedule; 4.) Improving Valuation of the Global Surgical Package; 5.) Improving Payment Accuracy for Primary Care and Care Management Services; 6.) Target for Relative Value Adjustments for Misvalued Services; 7.) Changes for Computed Tomography (CT) under the Protecting Access to Medicare Act of 2014 (PAMA); 8.) Malpractice RVUs; 9.) Validating RVUs of Service; 10.) Valuing New, Revised, and Potentially Misvalued Codes; 11.) Valuation of Specific Codes; 12.) Incident to Proposals: Billing Physicians as the Supervising Physician and Ancillary Personnel Requirements; 13.) Physicians Compare; 14.) Physician Payment, Efficiency, and Quality Improvements-Physician Quality Reporting System (PQRS); 15.) Value Based Modifier (VM) and Physician Feedback Reporting Program. H.R. 1919, the Steve Gleason Act of 2015; all provisions. S. 2425, the Patient Access and Medicare Protection Act; Section 4. Meaningful Use Incentive Program; in general. Physician-led, team-base care approach to healthcare models; in general. Comments regarding the Request for Information (RFI) on implementation of Alternative Payment Models (APMs) and Merit-Based Incentive Programs (MIPS) under the Medicare Access and Chip Reauthorization Act (MACRA). H.R. 2568, the Fair Medical Audits Act of 2015; all provisions. H.R. 2513, the Protecting Access, Competition, and Equity Act; all provisions. H.R. 3940, the Meaningful Use Hardship Relief Act of 2015; all provisions. Comments re: "Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and and other Revisions for Part B for CY 16" published in the Federal Register as a final rule with comment period on November 16, 2015, which address the following issues: 1) 2016 Conversion Factor (CF); 2) Practice Expense Issues; 3) Potentially Misvalued Services Under the Fee Schedule; 4) Improving Valuation of the Global Surgical Package; 5) Changes for Computed Tomography (CT) under the Protecting Access to Medicare Act of 2014 (PAMA); 6) Valuing New, Revised, and Potentially Misvalued Codes; 7) CY 2016 Interim Final Rule Codes; 8) Incident to Proposals: Billing Physicians as the Supervising Physician and Ancillary Personnel Requirements; 9) Physician Compare; 10) Physician Payment, Efficiency, and Quality Improvements - Physician Quality Reporting System (PQRS); 11) Value Based Payment Modifier (VM) and Physician Feedback Reporting Program. Comments re: the "Medicare and Medicaid Programs; Electronic Health Record Incentive Program--Stage 3 and Modifications to Meaningful Use in 2015-2017; Final Rule" published in the Federal Register on Friday, October 16, 2015, which address the following issues: 1) the need for increased flexibility; 2) the lack of interoperability; 3) the need for 90-day reporting periods beyond the current year; and 4) the specific meaningful use criteria.

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research; in general. Funding for Graduate Medical Education, in general. FY 2016 budgets; in general. Funding in the Fiscal Year (FY) 2016 Agriculture, Rural Development, and Food and Drug Administration (FDA) appropriations bill for the Pediatric Device Consortia (PDC) Grant Program at the Office of Orphan Products Development (OOPD) at FDA. H.R. 1344, the Early Hearing Detection and Intervention Act of 2015; all provisions. H.R. 1859, the Ensuring Childrens Access to Specialty Care Act of 2015; all provisions. Opposition to Section 747 of the House Agriculture Appropriations Bill with regards to FDAs authority under the Tobacco Control Act. Opposition to provisions in the FY 2016 Labor, Health and Human Services, Education and Related Agencies appropriations bill to eliminate, or reduce, funding for the Agency for Healthcare Research and Quality (AHRQ). Opposition to language in the FY16 House Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill that would cut funding for tobacco prevention at the CDC Office on Smoking and Health by 50 percent. Opposition to proposed "rider" language in the FY 16 House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill that changes the so-called grandfather date for e-cigarettes, cigars and other unregulated products and exempts these products from an important review requirement in the Tobacco Control Act (TCA). S. 2424, Early Hearing Detection and Intervention Act of 2015; all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Food and Drug Administration oversight of tobacco products; in general. H.R. 662/S. 441, the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2015; all provisions. Support for the Department of Housing and Urban Development requiring all government subsidized housing be made smokefree. Comments re: Administration's release of a Final "Deeming" regulation for tobacco products. H.R. 1375/S. 142, the Child Nicotine Poisoning Prevention Act; all provisions. H.R. 2058, the FDA Deeming Authority Clarification Act of 2015; all provisions. Comments to the US Preventive Services Task Force re: their draft recommendations for various tobacco cessation interventions. Opposition to Section 747 of the House Agriculture Appropriations Bill with regards to FDAs authority under the Tobacco Control Act. Trans-Pacific Partnership (TPP); relating to the inclusion of provisions/protections necessary to enable countries that are party to the agreement to protect the public health of their citizens from the death and disease caused by tobacco products. Communication to urge the the Food and Drug Administration (FDA) to commence an appropriate enforcement action against Reynolds American, Inc. (Reynolds) and its subsidiary Santa Fe Natural Tobacco Co. (Santa Fe) for the marketing of Natural American Spirit brand cigarettes in violation of the modified risk provisions of the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to language in the FY16 House Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill that would cut funding for tobacco prevention at the CDC Office on Smoking and Health by 50 percent. Opposition to proposed "rider" language in the FY 16 House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill that changes the so-called grandfather date for e-cigarettes, cigars and other unregulated products and exempts these products from an important review requirement in the Tobacco Control Act (TCA). Comments to the U.S. Food and Drug Administration (FDA) regarding the advanced notice of proposed rulemaking (ANPRM), Nicotine Exposure Warnings and Child-Resistant Packaging for Liquid Nicotine, Nicotine-Containing E-Liquid(s), and Other Tobacco Products; Request for Comments, published on July 1, 2015 (docket no. FDA-2015-N-1514). Comments regarding tobacco cessation interventions and preventive services, including guidance on insurance coverage of aforementioned.

Agencies Lobbied

Type of Issue

Lobbying Issues

H.R. 293, a bill to amend title XI (General Provisions, Peer Review, Administrative Simplification) of the Social Security Act to exempt from manufacturer transparency reporting to the Secretary of Health and Human Services any transfer of value to a covered recipient of: (1) peer-reviewed journals, journal reprints, journal supplements, conference reports, and medical textbooks that directly benefit patients or are intended for patient use; and (2) anything of value to a physician if it is intended solely to provide continuing medical education. H.R. 1741, the Truth in Healthcare Marketing Act of 2015; all provisions. Comments re: October 26, 2015, Presidents Council of Advisors on Science and Technology (PCAST) report to the President on Aging America & Hearing Loss: Imperative of Improved Hearing Technologies.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2015

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2015. Original Filing: 300763792.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research; in general. Funding for Graduate Medical Education, in general. FY 2016 budgets; in general. Funding in the Fiscal Year (FY) 2016 Agriculture, Rural Development, and Food and Drug Administration (FDA) appropriations bill for the Pediatric Device Consortia (PDC) Grant Program at the Office of Orphan Products Development (OOPD) at FDA. H.R. 1344, the Early Hearing Detection and Intervention Act of 2015; all provisions. H.R. 1859, the Ensuring Childrens Access to Specialty Care Act of 2015; all provisions. Opposition to Section 747 of the House Agriculture Appropriations Bill with regards to FDAs authority under the Tobacco Control Act. Opposition to provisions in the FY 2016 Labor, Health and Human Services, Education and Related Agencies appropriations bill to eliminate funding for the Agency for Healthcare Research and Quality (AHRQ). Opposition to language in the FY16 House Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill that would cut funding for tobacco prevention at the CDC Office on Smoking and Health by 50 percent. Opposition to proposed "rider" language in the FY 16 House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill that changes the so-called grandfather date for e-cigarettes, cigars and other unregulated products and exempts these products from an important review requirement in the Tobacco Control Act (TCA).

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2015

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 20, 2015. Original Filing: 300744194.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2015

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2015. Original Filing: 300725955.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2014

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2015. Original Filing: 300701836.xml

Lobbying Issues

Medicare Physician Payment Reform; in general. H.R. 4015/S. 2000, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014; all provisions. S. 2110, the Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. S. 2122, the Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. H.R. 4302, the Protecting Access to Medicare Act of 2014; all provisions. Audiology-related legislation, in general. H.R. 2330, the Medicare Audiology Services Enhancement Act of 2013; all provisions. H.R. 4035/S. 2046, the Access to Hearing Healthcare Act of 2014; all provisions. Repeal of the Independent Payment Advisory Board (IPAB); in general. Issue regarding Medicare appeals backlog; in general. Compliance with the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program; in general. Standards for electronic health records (EHR) Meaningful Use; in general. Comments on final 2014 Medicare Physician Fee Schedule rule; in general. Support for increased transparency at CMS to ensure that the rulemaking process for changes to the Medicare physician fee schedule under the misvalued codes initiative is transparent and allows for sufficient input by stakeholders well before the new values are implemented. H.R. 4695, a bill to amend title XVIII of the Social Security Act to add sleep apnea screening to the initial preventive physical examination under the Medicare program; all provisions. Comments re: CMS' final rule entitled Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Part II [CMS-3267-F] relating to changes to the Medicare hospital Conditions of Participation (CoPs). H.R. 4187, legislation to modify the current Medicare New Technology Add-on Payment (NTAP) Program to provide a new supplemental payment for certain antimicrobial drugs used in the hospital setting. H.R. 5304, the Audiology Patient Choice Act of 2014; all provisions. Concerns pertaining to implementation of the Physician Payments Sunshine Act (Sunshine Act) and subsequent requests for an expanded timeframe to allow recipients to register, review, and dispute their data in the Open Payments System before publication. Support for additional transparency and comment opportunity in the valuation of physician and other healthcare professional services re: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Centers for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015 - Proposal to Modify the Process for Establishing Values for New, Revised and Potentially Misvalued Codes. Comments re: the "Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies" published in the Federal Register as a proposed notice on July 11, 2014; provisions relating to the revision of the hearing aid exclusion to encompass osseointegrated implants and all other bone conducting prosthetics. Comments on the "Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Schedule & Other Revisions to Part B for CY 2015" published under the Federal Register as a proposed notice on July 11, 2014. Provisions relating to: (1) Sustainable Growth Rate (SGR); (2) Resource Based Practice Expense (PE) Relative Value Units (RVUs); (3) Potentially Misvalued Services Under the Fee Schedule; (4) Validating RVUs of Services; (5) Payment for Secondary Interpretation of Images; (6) Physician Compare Website; (7) Electronic Health Records (EHR) Meaningful Use (MU) Incentive Program; (8) Physician Quality Reporting System; and (9) Value Based Payment Modifier and Physician Feedback Program. Support for H.R. 5539, which would clarify that certain applicable manufacturer transfers of value to support independent medical educational programs and materials are exempt from reporting under the Physician Payments Sunshine Act (Sunshine Act). Comments regarding recent improvements and changes to the National Quality Forum (NQF) measure endorsement process; in general. Opposition to proposed policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global payment period codes to 0-day global period codes in 2017, and 2018, respectively. Comments re: the Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Schedule & Other Revisions to Part B for CY 2015 published in the Federal Register as a proposed notice on October 31, 2014. Our comments addressed the following issues, in the order in which they appear in the proposed rule: (1) Sustainable Growth Rate (SGR); (2) Resource Based Practice Expense (PE) Relative Value Units (RVUs); (3) Potentially Misvalued Services Under the Fee Schedule; (4) Validating RVUs of Services; (5) Payment for Secondary Interpretation of Images; (6) Physician Compare Website; (7) Electronic Health Records (EHR) Meaningful Use (MU) Incentive Program; (8) Physician Quality Reporting System; and (9) Value Based Payment Modifier and Physician Feedback Program.

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research; in general. Funding for graduate medical education (GME); in general. FY 2015 budgets; in general. Funding for the Pediatric Subspecialty Loan Repayment Program, Section 775 of the Public Health Service Act (42 U.S.C. 295f), in the Administration's FY2015 budget. Funding for the FY2015 Agriculture, Rural Development, and Food and Drug Administration (FDA) appropriations bill for the Pediatric Device Consortia (PDC) Grant Program at the Office of Orphan Products Development (OOPD) at FDA. Opposition to proposed language included in the House version of the National Defense Authorization Act for FY 2015 (NDAA FY 2015) bill that would prohibit the Secretary of Defense and the Secretaries of the military departments from implementing any new policy to limit, restrict, or ban the sale of any legal consumer product currently sold at commissaries or exchanges.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Food and Drug Administration oversight of tobacco products; in general. Clarification of tobacco cessation benefits in the Affordable Care Act; in general. Issues re: proposed changes in the design and composition of cigarettes to eliminate the increased risk of disease and death identified by the Surgeon General in the report released in January. Opposition to any amendment to Appropriations legislation that would exempt any type of cigar from regulation under the Family Smoking Prevention and Tobacco Control Act, P.L. 111-31, or would impede the current rulemaking process the Food and Drug Administration (FDA) has initiated to determine the appropriate level of oversight for tobacco products not currently regulated by the agency. Support for amendments to the FY2015 Transportation, Housing, and Urban Development Appropriations bill to require the Department of Transportation (DOT) to complete a 2011 rulemaking regarding the use of electronic cigarettes on aircraft within 90 days of enactment of the appropriations bill. Comments re: FDA's proposed regulation extending its jurisdiction to various "deemed" tobacco products, including electronic cigarettes. Support for the provision included in the Senate Defense Subcommittee's bill that directs the Secretary of Defense to eliminate price discounting for tobacco products sold in military commissaries and exchanges. H.R. 5486/S. 2581, the Child Nicotine Poisoning Prevention Act of 2014; all provisions. Opposition to proposed language included in the House version of the National Defense Authorization Act for FY 2015 (NDAA FY 2015) bill that would prohibit the Secretary of Defense and the Secretaries of the military departments from implementing any new policy to limit, restrict, or ban the sale of any legal consumer product currently sold at commissaries or exchanges.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2014

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 17, 2014. Original Filing: 300679563.xml

Lobbying Issues

Medicare Physician Payment Reform; in general. H.R. 4015/S. 2000, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014; all provisions. S. 2110, the Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. S. 2122, the Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; all provisions. H.R. 4302, the Protecting Access to Medicare Act of 2014; all provisions. Audiology-related legislation; in general. H.R. 2330, the Medicare Audiology Services Enhancement Act of 2013; all provisions. H.R. 4035/S. 2046, the Access to Hearing Healthcare Act of 2014; all provisions. H.R. 351/S. 351, the Protecting Seniors' Access to Medicare Act of 2013 and repeal of the Independent Payment Advisory Board (IPAB); in general. Issues regarding Medicare appeals backlog; in general. Compliance with the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program; in general. Standards for electronic health record (EHR) Meaningful Use; in general. Comments on final 2014 Medicare Physician Fee Schedule rule; in general. Support for increased transparency at CMS to ensure that the rulemaking process for changes to the Medicare physician fee schedule under the misvalued codes initiative is transparent and allows for sufficient input by stakeholders well before the new values are implemented. H.R. 4695, a bill to amend XVIII of the Social Security Act to add sleep apnea screening to the initial preventative physicial examination under the Medicare program; all provisions. Comments re: CMS' final rule entitled Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Part II [CMS-3267-F] relating to the Medicare hospital Conditions of Participation (CoPs). H.R. 4187, legislation to modify the current Medicare New Technology Add-on Payment (NTAP) Program to provide a new supplemental payment for certain antimicrobial drugs used in the hospital setting. H.R.5304, the Audiology Patient Choice Act of 2014; all provisions. Concerns pertaining to implementation of the Physician Payments Sunshine Act (Sunshine Act) and subsequent requests for an expanded timeframe to allow recipients to register, review, and dispute their data in the Open Payments System before publication. Support for additional transparency and comment opportunity in the valuation of physician and other healthcare professional services re: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Centers for Medicare & Medicaid Innovation Models & Other Revisions to Part B for CY 2015 - Proposal to Modify the Process for Establishing Values for New, Revised and Potentially Misvalued Codes. Comments re: the "Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies" published in the Federal Register as a proposed notice on July 11, 2014; provisions relating to the revision of the hearing aid exclusion to encompass osseointegrated implants and all other bone conducting prosthetics. Comments on the Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Schedule & Other Revisions to Part B for CY 2015 published in the Federal Register as a proposed notice on July 11, 2014. Provisions relating to: (1) Sustainable Growth Rate (SGR); (2) Resource Based Practice Expense (PE) Relative Value Units (RVUs); (3) Potentially Misvalued Services Under the Fee Schedule; (4) Validating RVUs of Services; (5) Payment for Secondary Interpretation of Images; (6) Physician Compare Website; (7) Electronic Health Records (EHR) Meaningful Use (MU) Incentive Program; (8) Physician Quality Reporting System; and (9) Value Based Payment Modifier and Physician Feedback Program.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Food and Drug Administration oversight of tobacco products; in general. Clarification of tobacco cessation benefits in the Affordable Care Act; in general. Issues re: proposed changes in the design and composition of cigarettes to eliminate the increased risk of disease and death identified by the Surgeon General in the report released in January. Opposition to any amendment to Appropriations legislation that would exempt any type of cigar from regulation under the Family Smoking Prevention and Tobacco Control Act, P.L. 111-31, or would impede the current rulemaking process the Food and Drug Administration (FDA) has initiated to determine the appropriate level of oversight for tobacco products not currently regulated by the agency. Support for amendments to the FY2015 Transportation, Housing and Urban Development Appropriations bill to require teh Department of Transportation (DOT) to complete a 2011 rulemaking regarding the use of electronic cigarettes on aircraft on within 90 days of enactment of the appropriations bill. Comments re: FDA's proposed regulation extending its jurisdiction to various "deemed" tobacco products, including electronic cigarettes. Support for the provision included in the Senate Defense Subcommittees bill that directs the Secretary of Defense to eliminate price discounting for tobacco products sold in commissaries and exchanges. H.R. 5486/S. 2581, the Child Nicotine Poisoning Prevention Act of 2014; all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2014

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 17, 2014. Original Filing: 300659972.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2014

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 17, 2014. Original Filing: 300639464.xml

Lobbying Issues

Medicare Physician Payment Reform; in general. H.R. 4015/S. 2000, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014. All provisions. S. 2110, the Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014. All provisions. S. 2122, the Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014. All provisions.S. 2157, the Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014. All provisions. H.R. 4302, the Protecting Access to Medicare Act of 2014. All provisions. Audiology-related legislation, in general. H.R. 2330, the Medicare Audiology Services Enhancement Act of 2013. All provisions. H.R. 4035/S. 2046, the Access to Hearing Healthcare Act of 2014. All provisions. Repeal of the Independent Payment Advisory Board (IPAB); in general. Issues regarding Medicare appeals backlog; in general. Compliance with the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program; in general. Standards for electronic health records (EHR) Meaningful Use; in general. Comments on final 2014 Medicare Physician Fee Schedule rule; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2013

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 16, 2014. Original Filing: 300617159.xml

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 351/S 351 - Protecting Seniors' Access to Medicare Act of 2013. HR 1331 - Electronic Health Records Improvement Act; all provisions. Opposition to audiology direct access to Medicare patients; in general.Implementation of ICD-10; in general. Sequestration; provisions relating to Medicare physician payment; in general. HR 2330 - Medicare Audiology Services Enhancement Act of 2013. Repeal of the Independent Payment Advisory Board (IPAB); in general. HR 2914 - Promoting Integrity in Medicare Act of 2013. Comments re: CMS proposal to cap payments in physician offices at facility rates CMS-1600-P; RIN 0938-AR56. Comments re: request for public comments on the potential release of Medicare physician data. HR 2810 - Medicare Patient Access and Quality Improvement Act of 2013; all provisions. Comments re: Medicare Program; Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2014. Final regulations re: the Sunshine Act and its impact on scientific peer reviewed medical journals and textbooks; in general. Efforts to encourage CMS' withdraw of its proposal to cap the practice expense portion of physician payments for 211 services at the OPPS or ASC rate; in general. Protection of funding for Graduate Medical Education; in general. Final 2014 Medicare Physician Fee Schedule rule; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research, in general. Inclusion of medical liability reform in budget proposals; in general. Funding for graduate medical education; in general. FY 2014 budgets, in general.Funding for Pediatric Subspecialty Loan Repayment program (Section 5203 of the Affordable Care Act); in general. FY 2014 Administrative Budget, provisions relating to limitations to the in-office ancillary services exemption. FY 2014 Agriculture, Rural Development, and Food and Drug Administration (FDA) appropriations bill - provisions relating to funding for the Pediatric Device Consortia program in the Office of Orphan Products Development at the FDA. HR 1827 - Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013; in general. Funding for the Pediatric Subspecialty Loan Repayment program, as authorized under Section 775 of the Public Health Service Act (42 U.S.C. 295f) in the FY 2014 Labor-Health and Human Services (HHS)-Education Appropriations bill; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2013

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 18, 2013. Original Filing: 300598001.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2013

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 12, 2013. Original Filing: 300571044.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2013

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 18, 2013. Original Filing: 300553071.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2012

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 17, 2013. Original Filing: 300532244.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012; all provisions. HR 452 - Medicare Decisions and Accountability Act of 2011; all provisions. S 668 - Healthcare Bureaucrats Elimination Act; all provisions.HR 2140/S. 3242 - Medicare Hearing Health Care Enhancement Act; all provisions. Policy guidance regarding how patients enrolled in Medicare may obtain reimbursement for covered services provided by physicians who choose not to enroll in Medicare and bill their patients directly; in general. Proposed Rule - "Medicare, Medicaid, Children's Heatlh Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests", 42 CFR Parts 402 and 403 [CMS-5060-P] RIN 0938-AR33; in general. HR 5 - The Protecting Access to Healthcare (PATH) Act; all provisions. Agency Information Collection Activities: Prosposed Collection; Comment Request [CMS-10421]. Budget Control Act and Sequestration - provisions relating to Medicare physician payment. CMS Proposed Rule: Medicare and Medicaid Programs; Electronic Health Record Incentive ProgramStage 2 - provisions relating to the Stage 2 of meaningful use objectives and measures that must be met by eligible professionals (EPs)2 to ensure receipt of the financial incentives and avoid the penalties specified by the American Recovery and Reinvestment Act of 2009 (ARRA). H.R. 6598 - Electronic Health Records Improvement Act; all provisions. Implementation of ICD-10; in general. 2013 Medicare Physician Fee Schedule Final Rule; in general. H.R. 8 - American Taxpayer Relief Act of 2012; in general. Opposition to the proposed "Promoting Integrity in Medicare Act of 2011," regarding self-referral of imaging services.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

S 1461 - Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011; all provisions. Food and Drug Administration oversight of tobacco products; in general. Comments on the implementation of smokefree policies in multi-unit housing as requested in the Federal Register on October 4, 2012 (Docket No. FR-5597-N-01).Comments in opposition to the Petition of R.J. Reynolds TobaccoCompany (RJR) and the American Snuff Company (ASC), Reynolds American, Inc.s smokeless tobacco subsidiary, request that the Commissioner of Food and Drugs initiate a rulemaking proceeding to alter the text of the statutorily-required smokeless tobacco (ST) product warning statement. Comment on CMS-9980-P, the proposed rule on the Patient Protection and Affordable Care Act (ACA), standards related to Essential Health Benefits (EHB), actuarial value, and accreditation; provisions relating to smoking cessation and applicable insurance coverage.

Agencies Lobbied

Type of Issue

3rd Quarter, 2012

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 17, 2012. Original Filing: 300509298.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2012

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 19, 2012. Original Filing: 300492458.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2012

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 5, 2012. Original Filing: 300457965.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012; all provisions HR 452 - Medicare Decisions and Accountability Act of 2011; all provisions. S 668 - Healthcare Bureaucrats Elimination Act; all provisions.HR 2140 - Medicare Hearing Health Care Enhancement Act; all provisions. Policy guidance regarding how patients enrolled in Medicare may obtain reimbursement for covered services provided by physicians who choose not to enroll in Medicare and bill their patients directly; in general. Proposed Rule - Medicare, Medicaid, Childrens Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests, 42 CFR Parts 402 and 403 [CMS-5060-P] RIN 0938-AR33; in general. HR 5 - The Protecting Access to Healthcare (PATH) Act; all provisions. Physician Fee Schedule Proposed Rule for calendar year 2013; all provisions. Agency Information Collection Activities: Proposed Collection; Comment Request [CMS-10421].

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2011

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 19, 2012. Original Filing: 300444972.xml

Lobbying Issues

HR 2 - Repealing the Job-Killing Health Care Law; all provisions. HR 451 - Healthcare Truth and Transparency Act of 2011; all provisions. HR 969 - Medical Practice Freedom Act of 2011; all provisions. HR 1955/S 1045 - The Children's Access to Reconstructive Evaluation and Surgery (CARES) Act; all provisions.Comments on the Health Information Technology Policy Committee's (HITPC) proposal for Stage 2 if the Meaningful Use of Electronic Health Records (EHRs). HR 2092/S 1278 - To amend the Internal Revenue Code of 1986 to repeal the excise tax on indoor tanning services; all provisions. Recommendations concerning patient-centered outcomes research national priorities, patient-centered outcomes research definition, and proposed Tier 1 grant projects; in general. National Quality Forum; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 1256 - Medicare Physician Payment Transparency and Assessment Act; all provisions. Medicare Physician Payment Advisory Commission March 2011 Report to Congress: Medicare Payment Policy. S 756 - Medicare Data Access for Transparency and Accountability Act; all provisions.S 848 - a bill to provide for the development of reports based on Medicare data, data that is publicly available, or private data that is provided by a requesting entity in order to improve the quality and efficiency of health care. Medicare Physician Supervision Requirement for CPT 31579 & 92511. Proposed Rule - Accountable Care Organizations; all provisions. HR 452 - Medicare Decisions and Accountability Act of 2011; all provisions. S 668 - Health Care Bureaucrats Elimination Act; all provisions. HR 2140 - Medicare Hearing Health Care Enhancement Act of 2011; all provisions. HR 1700/S 1042 - Medicare Patient Empowerment Act; all provisions. HR 1476 - Integrity in Medicare Advanced Diagnostics Imaging Act of 2011; all provisions. Medicare Payment Advisory Commission June 2011 Report to Congress; all provisions. 2011 Medicare physician fee schedule; all provisions. Continued funding for Graduate Medical Education (GME); in general. Centers for Medicare and Medicaid Services program changes re: tobacco cessation quitline services for Medicaid beneficiaries and expansion for Medicaid coverage of tobacco cessation servicse for pregnant women. Medicare Payment Advisory Commission (MedPAC) - proposed changes to Medicare physician payment system. Changes to supervision level for CPT code 92511 (Laryngoscopy, flexible or rigid fiberoptic, with stroboscopy) and code 92511 (Nasopharyngoscopy with endoscope). Medicare and Medicaid Programs; Reform of Hospital and Critical Access Hospital Conditions of Participation [CMS-3244-P]. HR 3630 - Temporary Payroll Tax Cut Continuation Act of 2011; all provisions and amendments.

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research; in general. HR 531 - Access to Frontline Health Care Act of 2011; all provisions. HR 1217 - To repeal the Prevention and Public Health Fund; all provisions. Funding for trauma and EMS services; in general.HR 2112 - FY 2012 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill; provisions relating to changes to the Family Smoking Prevention and Tobacco Control Act. Deficit Reduction Proposals - provisions relating to Medicare, Graduate Medical Education, repeal of the Sustainable Growth Rate (SGR) formula and the Independent Paymetn Advisory Board (IPAB), and medical liability reform. S 365 - Budget Control Act of 2011; all provisions. FY 2012 Budget; provisions relating to the continued funding for Children's Hospitals Graduate Medical Education (CHGME). Funding for Section 5203, "Health Care Workforce Loan Repayment Programs" of the Affordable Care Act. HR 1852/S 958 - Children's Hospital GME Support Reauthorization Act of 2011, all provisions. Communications with Joint Select Committee on Deficit Reduction; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2011

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2011. Original Filing: 300424204.xml

Lobbying Issues

HR 2 - Repealing the Job-Killing Health Care Law; all provisions. HR 451 - Healthcare Truth and Transparency Act of 2011; all provisions. S 668 - Health Care Bureaucrats Elimination Act; all provisions. HR 969 - Medical Practice Freedom Act of 2011; all provisions.Comments on the Health Information Technology Policy Committee's (HITPC) proposal for Stage 2 of the Meaningful Use of Electronic Health Records (EHRs). HR 1955/S 1045 - The Children's Access to Reconstructive Evaluation and Surgery (CARES) Act; all provisions. HR 2092/S 1278 - To amend the Internal Revenue Code of 1986 to repeal the excise tax on indoor tanning services; all provisions. Recommendations concerning patient-centered outcomes research national priorities, patient centered outcomes research definition, and proposed Tier 1 grant projects; in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 1256 - Medicare Physician Payment Transparency and Assessment Act; all provisions. Medicare Physician Payment Advisory Commission March 2011 Report to Congress: Medicare Payment Policy. S 756 - Medicare Data Access for Transparency and Accountability Act; all provisions.S 848 - A bill to provide for the development of reports based on Medicare data, data that is publicly available, or private data that is provided by a requesting entity in order to improve the quality and efficiency of health care. Medicare Physician Supervision Requirement for CPT 31579 & 92511. Proposed Rule - Accountable Care Organizations; all provisions. HR 452 - Medicare Decisions and Accountability Act of 2011; all provisions. HR 2140 - Medicare Hearing Health Care Enhancement Act of 2011; all provisions HR 1700/S 1042 - Medicare Patient Empowerment Act; all provisions. HR 1476 - Integrity in Medicare Advanced Diagnostic Imaging Act of 2011; all provisions. Medicare Payment Advisory Commission June 2011 Report to Congress; all provisions. 2011 Medicare physician fee schedule; all provisions. Continued funding for Graduate Medical Education (GME); in general. Centers for Medicare and Medicaid Services program changes re: tobacco cessation quitline services for Medicaid beneficiaries and expansion of Medicaid coverage of tobacco cessation services for pregnant women. Medicare Payment Advisory Commission (MedPAC) - proposed changes to Medicare physician payment system. Changes to supervision level for CPT code 92511 (Laryngoscopy, flexible or rigid fiberoptic, with stroboscopy) and code 92511 (Nasopharyngoscopy with endoscope).

Agencies Lobbied

Type of Issue

Lobbying Issues

Funding for NIH and medical research; in general. HR 531 - Access to Frontline Health Care Act of 2011; all provisions. HR 1217 - To repeal the Prevention and Public Health Fund; all provisions. Funding for trauma and EMS services; in general.HR 2112 - FY 2012 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill; provisions relating to changes to the Family Smoking Prevention and Tobacco Control Act. Deficit Reduction Proposals - provisions relating to Medicare, Graduate Medical Education, repeal of the Sustainable Growth Rate (SGR) formula and the Independent Payment Advisory Board (IPAB), and medical liability reform. S 365 - Budget Control Act of 2011; all provisions. FY 2012 Budget; provisions relating to continued funding for Children's Hospitals Graduate Medical Education (CHGME). Funding for Section 5203, Health Care Workforce Loan Repayment Programs of the Affordable Care Act. HR 1852/S 958 - Children's Hospital GME Support Reauthorization Act of 2011

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2011

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 19, 2011. Original Filing: 300396654.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 20, 2011. Original Filing: 300378666.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2010

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 20, 2011. Original Filing: 300351657.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform; in general. HR 4691 - Temporary Extensions Act of 2010; all provisions. HR 4851 - Continuing Extensions Act of 2010; all provisions. HR 4213 - American Jobs and Closing Tax Loopholes Act of 2010; all provisions.HR 3024 - Medicare Hearing and Healthcare Enhancement Act of 2009; all provisions. HR 4895 - Medicare Decisions Accountability Act of 2010; all provisions. HR 3962 - Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010; all provisions. MedPAC Report to Congress, June 2010; all provisions. Ambulatory Surgical Centers (ASCs) payments; in general. Medicare physician participation status; in general. HR 4994 - Medicare and Medicaid Extensions Act of 2010; all provisions. HR 5712 - Physician Payment and Therapy Relief Act of 2010; all provisions. 2011 Medicare Payment Fee Schedule; all provisions. Reinstatement of consultation codes, in general. Transition to ICD-10 and Version 5010 of HIPAA, in general. Implementation of electronic health records and e-prescribing, in general. Medicare, Medicaid, and Children's Health Insurance Programs proposed rule on program integrity; all provisions. Accountable Care Organizations, in general.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2010

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 19, 2010. Original Filing: 300318955.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2010

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 22, 2010. Original Filing: 300304588.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2010

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 19, 2010. Original Filing: 300265260.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2009

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 18, 2010. Original Filing: 300234508.xml

Lobbying Issues

H.R. 1339 - Children's Access to Reconstructive Evaluation & Surgery (CARES) Act; all provisions. H.R. 1 - American Recovery and Reinvestment Act; provisions dealing with Health Information Techonology and comparative effectivness research. H.R. 1256, S. 982 - Family Smoking Prevention and Tobacco Control Act; all provisions.H.R. 2891 - Access to Frontline Health Care Act of 2009; all provisions. Physician workforce and residency training. Healthcare truth and transparency. Trauma and emergency care. General quality improvement in healthcare delivery. Legislation affecting specialty/physician-owned hospitals. H.R. 3584 - Small Business Financing and Investment Act of 2009; Section VI, HIT Provisions. Healthcare Reform Senate HELP Committee Legislation - America's Affordable Health Choices Act; all provisions. Senate Finance Committee Legislation - America's Healthly Future Act; all provisions. H.R. 3200 - America's Affordable Health Choices Act; all provisions. H.R. 3962 - Affordable Healthcare for America Act; all provisions. H.R. 3590 - The Patient Protection and Affordable Care Act; all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Medicare Physician Payment Reform. CMS Transmittals - 84,1470 and 1550 - "Incident to" policy relating to audiology services. H.R. 3024 - Medicare Hearing Healthcare Enhancement Act of 2009; all provisions. H.R. 2718 - Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009; all provisionsH.R. 2844 - Medicare Payment Improvement Act of 2009; all provisions. S. 1110 - Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009; all provisions. S. 950 Medicare Patient Access to Physical Therapists Act of 2009; all provisions. S. 1776 - Medicare Physician Fairness Act of 2009; all provisions H.R. 3961 - Medicare Physician Payment Reform Act of 2009; all provisions. H.R. 4371 - To amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2009

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 13, 2009. Original Filing: 300203645.xml

Lobbying Issues

H.R. 1339- Childrens Access to Reconstructive Evaluation & Surgery (CARES) Act; all provisions. H.R. 1- American Recovery and Reinvestment Act; provisions dealing with Health Information Tecnology and comparative effectivness research. H.R. 1256/S. 982- Family Smoking Prevention and Tobacco Regulation Control Act; all provisions.H.R. 2891- Access to Frontline Health Care Act of 2009, all provisions. Physician workforce and residency training. Healthcare truth and transparency. Trauma and emergency care. General quality improvement in healthcare delivery. Legislation affecting specialty/physician owned hopsitals. Healthcare Reform Senate Help Committee Legislation- America's Affordable Health Choices Act, all provisions. Senate Finance Committee Legislation, America's Healthy Futrure Act, all provisions. H.R. 3200, America's Afforable Health Choices Act, all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2009

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 16, 2009. Original Filing: 300181088.xml

Lobbying Issues

H.R. 1339- Childrens Access to Reconstructive Evaluation & Surgery (CARES) Act; all provisions. H.R. 1- American Recovery and Reinvestment Act; provisions dealing with Health Information Tecnology and comparative effectivness research. H.R. 1256/S. 982- Family Smoking Prevention and Tobacco Regulation Control Act; all provisions.H.R. 2891- Access to Frontline Health Care Act of 2009, all provisions. Physician workforce and residency training. Healthcare truth and transparency. Trauma and emergency care. General quality improvement in healthcare delivery. Legislation affecting specialty/physician owned hopsitals. Healthcare Reform Senate Help Committee Legislation- Affordable Health Choices Act, all provisions. Senate Finance Committee Legislation, all provisions. H.R. 3200, America's Afforable Health Choices Act, all provisions.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2009

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 15, 2009. Original Filing: 300149530.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2008

Q4 Report

In Q4, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Jan. 14, 2009. Original Filing: 300118490.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

HR 1665/S 2352- Medicare Hearing Health Care Enhancement Act of 2007, all provisions. HR 1823/S 2250- Ambulatory Surgical Center Medicare Payment Modernization Act of 2007, all provisions. HR 1774/S 45- Establishes a separate definition of outpatient speech-language pathology services under Medicare, all provisions. S 2785- Save Medicare Act of 2008, all provisions.S. 3101 - Medicare Improvements for Patients and Providers Act of 2008, all provisions S. 3118 - Preserving Access to Medicare Act of 2008, all provisions HR 6331- Medicare Improvements for Patients and Providers Act of 2008, all provisions HR 2585/S 2729- Ensuring the Future Physician Workforce Act of 2008, all provisions. HR 5445- To amend part B of title XVIII of the Social Security Act to increase Medicare payments for physicians' services through December 31, 2009, all provisions. CMS Transmittals- 84, 1470, and 1550 - "Incident to" policy relating to audiology services.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2008

Q3 Report

In Q3, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Oct. 20, 2008. Original Filing: 300106654.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2008

Q2 Report

In Q2, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on July 9, 2008. Original Filing: 300062552.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2008

Q1 Report

In Q1, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on April 15, 2008. Original Filing: 300037500.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

0th Quarter, 2007

MM Report

In MM, AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY had in-house lobbyists. The report was filed on Aug. 6, 2007. Original Filing: 200046253.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Legislators

Bills

Statements

Lobbying

Travel

Lobbyists

Disclosures Filed